Cot	B-protein
kinase	I-protein
induces	O
cyclooxygenase-2	O
expression	O
in	O
T	B-cell_type
cells	I-cell_type
through	O
activation	O
of	O
the	O
nuclear	B-protein
factor	I-protein
of	I-protein
activated	I-protein
T	I-protein
cells	I-protein
.	O

Cyclooxygenase-2	B-protein
(	O
COX-2	B-protein
)	O
is	O
induced	O
in	O
human	B-cell_type
T	I-cell_type
lymphocytes	I-cell_type
upon	O
T	B-protein
cell	I-protein
receptor	I-protein
triggering	O
.	O

Here	O
we	O
report	O
that	O
Cot	B-protein
kinase	I-protein
,	O
a	O
mitogen-activated	B-protein
protein	I-protein
kinase	I-protein
kinase	I-protein
kinase	I-protein
involved	O
in	O
T	O
cell	O
activation	O
,	O
up-regulates	O
COX-2	B-DNA
gene	I-DNA
expression	O
in	O
Jurkat	B-cell_line
T	I-cell_line
cells	I-cell_line
.	O

Induction	O
of	O
COX-2	O
promoter	O
activity	O
by	O
Cot	B-protein
kinase	I-protein
occurred	O
mainly	O
through	O
activation	O
of	O
the	O
nuclear	B-protein
factor	I-protein
of	I-protein
activated	I-protein
T	I-protein
cells	I-protein
(	O
NFAT	B-protein
)	O
.	O

Mutation	O
of	O
the	O
distal	B-DNA
(	I-DNA
-105/-97	I-DNA
)	I-DNA
and	O
proximal	B-DNA
(	I-DNA
-76/-61	I-DNA
)	I-DNA
NFAT	B-DNA
response	I-DNA
elements	I-DNA
in	O
the	O
COX-2	B-DNA
promoter	I-DNA
abolished	O
the	O
activation	O
induced	O
by	O
Cot	B-protein
kinase	I-protein
.	O

Even	O
more	O
,	O
coexpression	O
of	O
a	O
dominant	O
negative	O
version	O
of	O
NFAT	B-protein
inhibited	O
Cot	B-protein
kinase	I-protein
-mediated	O
COX-2	B-DNA
promoter	I-DNA
activation	O
,	O
whereas	O
cotransfection	O
of	O
a	O
constitutively	O
active	O
version	O
of	O
the	O
calcium-dependent	B-protein
phosphatase	I-protein
calcineurin	I-protein
synergizes	O
with	O
Cot	B-protein
kinase	I-protein
in	O
the	O
up-regulation	O
of	O
COX-2	B-DNA
promoter	I-DNA
-driven	O
transcription	O
.	O

Strikingly	O
,	O
Cot	B-protein
kinase	I-protein
increased	O
transactivation	O
mediated	O
by	O
a	O
GAL4-NFAT	B-protein
fusion	I-protein
protein	I-protein
containing	O
the	O
N-terminal	B-protein
transactivation	I-protein
domain	I-protein
of	O
NFATp	B-protein
.	O

In	O
contrast	O
to	O
phorbol	O
ester	O
plus	O
calcium	O
ionophore	O
A23187	O
,	O
Cot	B-protein
kinase	I-protein
increases	O
both	O
COX-2	B-DNA
promoter	I-DNA
activity	O
and	O
NFAT	B-protein
-mediated	O
transactivation	O
in	O
a	O
cyclosporin	O
A-independent	O
manner	O
.	O

These	O
data	O
indicate	O
that	O
Cot	B-protein
kinase	I-protein
up-regulates	O
COX-2	B-DNA
promoter	I-DNA
-driven	O
transcription	O
through	O
the	O
NFAT	B-DNA
response	I-DNA
elements	I-DNA
,	O
being	O
the	O
Cot	B-protein
kinase	I-protein
-induced	O
NFAT	B-protein
-dependent	O
transactivation	O
presumably	O
implicated	O
in	O
this	O
up-regulation	O
.	O

THE	NULL
JOURNAL	NULL
oF	NULL
BIOLOGICAL	NULL
CHEMISTRY	NULL
©	NULL
2001	NULL
by	NULL
The	NULL
American	NULL
Society	NULL
for	NULL
Biochemistry	NULL
and	NULL
Molecular	NULL
Biology	NULL
,	NULL
Inc.	NULL
Vol	NULL
.	NULL

276	NULL
,	NULL
No	NULL
.	NULL

29	NULL
,	NULL
Issue	NULL
of	NULL
July	NULL
20	NULL
,	NULL
pp	NULL
.	NULL

27003-27009	NULL
,	NULL
2001	NULL
Printed	NULL
in	NULL
U.S.A.	NULL
Cot	NULL
Kinase	NULL
Induces	NULL
Cyclooxygenase-2	NULL
Expression	NULL
in	NULL
T	NULL
Cells	NULL
through	NULL
Activation	NULL
of	NULL
the	NULL
Nuclear	NULL
Factor	NULL
of	NULL
Activated	NULL
T	NULL
Cells*	NULL
Received	NULL
for	NULL
publication	NULL
,	NULL
January	NULL
30	NULL
,	NULL
2001	NULL
,	NULL
and	NULL
in	NULL
revised	NULL
form	NULL
,	NULL
May	NULL
16	NULL
,	NULL
2001	NULL
Published	NULL
,	NULL
JBC	NULL
Papers	NULL
in	NULL
Press	NULL
,	NULL
May	NULL
16	NULL
,	NULL
2001	NULL
,	NULL
DOI	NULL
10.1074/jbe.M100885200	NULL
Rosa	NULL
de	NULL
Gregorio	NULL
$	NULL
§	NULL
,	NULL
Miguel	NULL
A.	NULL
Iniguez	NULL
#	NULL
1	NULL
,	NULL
Manuel	NULL
Fresno1	NULL
,	NULL
and	NULL
Susana	NULL
Alemany	NULL
}	NULL
From	NULL
the	NULL
Instituto	NULL
de	NULL
Investigaciones	NULL
Biomédicas	NULL
,	NULL
Consejo	NULL
Superior	NULL
de	NULL
Investigaciones	NULL
Cientificas	NULL
(	NULL
CSIC	NULL
)	NULL
,	NULL
Facultad	NULL
Medicina	NULL
,	NULL
Universidad	NULL
Auténoma	NULL
de	NULL
Madrid	NULL
(	NULL
UAM	NULL
)	NULL
,	NULL
Arturo	NULL
Duperier	NULL
4	NULL
,	NULL
E-28029	NULL
Madrid	NULL
,	NULL
and	NULL
the	NULL
(	NULL
Centro	NULL
de	NULL
Biologia	NULL
Molecular	NULL
,	NULL
CSIC-UAM	NULL
,	NULL
Cantoblanco	NULL
,	NULL
Madrid	NULL
E-28049	NULL
,	NULL
Spain	NULL
Cyeclooxygenase-2	NULL
(	NULL
COX-2	NULL
)	NULL
is	NULL
induced	NULL
in	NULL
human	NULL
T	NULL
lymphocytes	NULL
upon	NULL
T	NULL
cell	NULL
receptor	NULL
triggering	NULL
.	NULL

Here	NULL
we	NULL
report	NULL
that	NULL
Cot	NULL
kinase	NULL
,	NULL
a	NULL
mitogen-activated	NULL
protein	NULL
kinase	NULL
kinase	NULL
kinase	NULL
involved	NULL
in	NULL
T	NULL
cell	NULL
activation	NULL
,	NULL
up-regulates	NULL
COX-2	NULL
gene	NULL
expression	NULL
in	NULL
Jurkat	NULL
T	NULL
cells	NULL
.	NULL

Induction	NULL
of	NULL
COX-2	NULL
promoter	NULL
activity	NULL
by	NULL
Cot	NULL
kinase	NULL
occurred	NULL
mainly	NULL
through	NULL
activation	NULL
of	NULL
the	NULL
nuclear	NULL
factor	NULL
of	NULL
activated	NULL
T	NULL
cells	NULL
(	NULL
NFAT	NULL
)	NULL
.	NULL

Mutation	NULL
of	NULL
the	NULL
distal	NULL
(	NULL
-105/-97	NULL
)	NULL
and	NULL
proximal	NULL
(	NULL
-76/-61	NULL
)	NULL
NFAT	NULL
response	NULL
elements	NULL
in	NULL
the	NULL
COX-2	NULL
promoter	NULL
abolished	NULL
the	NULL
activation	NULL
induced	NULL
by	NULL
Cot	NULL
kinase	NULL
.	NULL

Even	NULL
more	NULL
,	NULL
coexpression	NULL
of	NULL
a	NULL
dominant	NULL
negative	NULL
version	NULL
of	NULL
NFAT	NULL
inhibited	NULL
Cot	NULL
kinase-mediated	NULL
COX-2	NULL
promoter	NULL
activation	NULL
,	NULL
whereas	NULL
cotransfection	NULL
of	NULL
a	NULL
constitutively	NULL
active	NULL
version	NULL
of	NULL
the	NULL
calcium-dependent	NULL
phosphatase	NULL
calcineurin	NULL
synergizes	NULL
with	NULL
Cot	NULL
kinase	NULL
in	NULL
the	NULL
up-regulation	NULL
of	NULL
COX-2	NULL
promoter-driven	NULL
transcription	NULL
.	NULL

Strikingly	NULL
,	NULL
Cot	NULL
kinase	NULL
increased	NULL
transactivation	NULL
mediated	NULL
by	NULL
a	NULL
GAL4-NFAT	NULL
fusion	NULL
protein	NULL
containing	NULL
the	NULL
N-terminal	NULL
transactivation	NULL
domain	NULL
of	NULL
NFAT	NULL
p.	NULL
In	NULL
contrast	NULL
to	NULL
phorbol	NULL
ester	NULL
plus	NULL
calcium	NULL
ionophore	NULL
A23187	NULL
,	NULL
Cot	NULL
kinase	NULL
increases	NULL
both	NULL
COX-2	NULL
promoter	NULL
activity	NULL
and	NULL
NFAT-mediated	NULL
transactivation	NULL
in	NULL
a	NULL
cyclosporin	NULL
A-inde-pendent	NULL
manner	NULL
.	NULL

These	NULL
data	NULL
indicate	NULL
that	NULL
Cot	NULL
kinase	NULL
up-regulates	NULL
COX-2	NULL
promoter-driven	NULL
-	NULL
transcription	NULL
through	NULL
the	NULL
NFAT	NULL
response	NULL
elements	NULL
,	NULL
being	NULL
the	NULL
Cot	NULL
kinase-induced	NULL
NFAT-dependent	NULL
transactivation	NULL
presumably	NULL
implicated	NULL
in	NULL
this	NULL
up-regulation	NULL
.	NULL

Cot/Tpl-2	NULL
kinase	NULL
has	NULL
been	NULL
implicated	NULL
in	NULL
cellular	NULL
activation	NULL
and	NULL
transformation	NULL
(	NULL
1-6	NULL
)	NULL
.	NULL

This	NULL
kinase	NULL
was	NULL
initially	NULL
discovered	NULL
in	NULL
a	NULL
truncated	NULL
form	NULL
(	NULL
6	NULL
,	NULL
7	NULL
)	NULL
that	NULL
provides	NULL
higher	NULL
oncogenic	NULL
ca-pacity	NULL
,	NULL
although	NULL
overexpression	NULL
of	NULL
the	NULL
normal	NULL
gene	NULL
is	NULL
also	NULL
capable	NULL
of	NULL
conferring	NULL
a	NULL
transformed	NULL
phenotype	NULL
in	NULL
established	NULL
cell	NULL
lines	NULL
(	NULL
7-10	NULL
)	NULL
.	NULL

The	NULL
Cot/Tpl-2	NULL
protein	NULL
,	NULL
which	NULL
is	NULL
homologous	NULL
to	NULL
members	NULL
of	NULL
the	NULL
mitogen-activated	NULL
protein	NULL
kinase	NULL
kinase	NULL
kinase	NULL
family	NULL
(	NULL
1-5	NULL
)	NULL
,	NULL
regulates	NULL
the	NULL
activity	NULL
of	NULL
different	NULL
transduction	NULL
pathways	NULL
that	NULL
converge	NULL
into	NULL
the	NULL
activation	NULL
of	NULL
several	NULL
mitogen-activated	NULL
protein	NULL
kinases	NULL
:	NULL
c-Jun	NULL
N-terminal	NULL
kinase	NULL
and	NULL
extra-cellular	NULL
signal-regulated	NULL
kinases	NULL
1	NULL
(	NULL
p42/44	NULL
)	NULL
,	NULL
6	NULL
(	NULL
p387	NULL
)	NULL
,	NULL
and	NULL
5	NULL
(	NULL
1	NULL
,	NULL
10-12	NULL
)	NULL
.	NULL

Cot/Tpl-2	NULL
kinase	NULL
plays	NULL
an	NULL
important	NULL
role	NULL
in	NULL
T	NULL
cell	NULL
*	NULL
This	NULL
work	NULL
was	NULL
supported	NULL
in	NULL
part	NULL
by	NULL
Grants	NULL
PM97-0130	NULL
and	NULL
FD97-0275	NULL
from	NULL
Laboratorios	NULL
Dr.	NULL
Esteve	NULL
,	NULL
Boehringer	NULL
Ingelheim	NULL
,	NULL
Direccion	NULL
General	NULL
de	NULL
Ensefianza	NULL
Superior	NULL
e	NULL
Investigacion	NULL
Cientificas	NULL
of	NULL
Spain	NULL
,	NULL
by	NULL
Grant	NULL
SAF99-0067	NULL
from	NULL
the	NULL
Plan	NULL
Nacional	NULL
,	NULL
Comunidad	NULL
Auténoma	NULL
de	NULL
Madrid	NULL
,	NULL
and	NULL
the	NULL
Fundacion	NULL
Ramon	NULL
Areces	NULL
.	NULL

The	NULL
costs	NULL
of	NULL
publication	NULL
of	NULL
this	NULL
article	NULL
were	NULL
defrayed	NULL
in	NULL
part	NULL
by	NULL
the	NULL
payment	NULL
of	NULL
page	NULL
charges	NULL
.	NULL

This	NULL
article	NULL
must	NULL
therefore	NULL
be	NULL
hereby	NULL
marked	NULL
``	NULL
advertisement	NULL
``	NULL
in	NULL
accordance	NULL
with	NULL
18	NULL
U.S.C	NULL
.	NULL

Section	NULL
1734	NULL
solely	NULL
to	NULL
indicate	NULL
this	NULL
fact	NULL
.	NULL

J	NULL
These	NULL
authors	NULL
contributed	NULL
equally	NULL
to	NULL
this	NULL
work	NULL
.	NULL

§	NULL
Supported	NULL
by	NULL
a	NULL
Consejo	NULL
Superior	NULL
de	NULL
Investigaciones	NULL
Cientfficas	NULL
sector	NULL
empresarial	NULL
fellowship	NULL
.	NULL

|	NULL
To	NULL
whom	NULL
correspondence	NULL
should	NULL
be	NULL
addressed	NULL
.	NULL

Fax	NULL
:	NULL
34-91-585-4587	NULL
.	NULL

This	NULL
paper	NULL
is	NULL
available	NULL
on	NULL
line	NULL
at	NULL
http	NULL
:	NULL
//www.jbc.org	NULL
activation	NULL
,	NULL
promoting	NULL
tumor	NULL
necrosis	NULL
factor-a	NULL
and	NULL
interleukin-2	NULL
production	NULL
by	NULL
activating	NULL
the	NULL
transcription	NULL
of	NULL
these	NULL
genes	NULL
(	NULL
13-15	NULL
)	NULL
.	NULL

Cot/Tpl-2	NULL
regulation	NULL
of	NULL
gene	NULL
transcription	NULL
occurs	NULL
mainly	NULL
through	NULL
activation	NULL
of	NULL
several	NULL
transcription	NULL
factors	NULL
such	NULL
as	NULL
AP-1	NULL
'	NULL
(	NULL
10	NULL
,	NULL
12	NULL
,	NULL
14	NULL
)	NULL
,	NULL
NFAT	NULL
(	NULL
14-16	NULL
)	NULL
,	NULL
and	NULL
NF-	NULL
«	NULL
B	NULL
(	NULL
16-18	NULL
)	NULL
.	NULL

Two	NULL
enzymes	NULL
,	NULL
cyclooxygenase-1	NULL
(	NULL
COX-1	NULL
)	NULL
and	NULL
cyclooxygenase-2	NULL
(	NULL
COX-2	NULL
)	NULL
,	NULL
catalyze	NULL
the	NULL
rate-limiting	NULL
step	NULL
in	NULL
the	NULL
synthesis	NULL
of	NULL
prostaglandins	NULL
(	NULL
for	NULL
review	NULL
,	NULL
see	NULL
Ref	NULL
.	NULL

19	NULL
)	NULL
.	NULL

COX-1	NULL
is	NULL
a	NULL
consti-tutive	NULL
enzyme	NULL
thought	NULL
to	NULL
be	NULL
involved	NULL
in	NULL
``	NULL
housekeeping	NULL
``	NULL
func-tions	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
COX-2	NULL
is	NULL
induced	NULL
in	NULL
a	NULL
variety	NULL
of	NULL
cell	NULL
types	NULL
by	NULL
diverse	NULL
stimuli	NULL
including	NULL
growth	NULL
factors	NULL
,	NULL
mitogens	NULL
,	NULL
cytokines	NULL
,	NULL
and	NULL
tumor	NULL
promoters	NULL
(	NULL
19	NULL
)	NULL
.	NULL

COX-2	NULL
is	NULL
induced	NULL
in	NULL
T	NULL
lymphocytes	NULL
upon	NULL
T	NULL
cell	NULL
receptor	NULL
activation	NULL
,	NULL
suggesting	NULL
functional	NULL
implications	NULL
of	NULL
this	NULL
enzyme	NULL
in	NULL
this	NULL
process	NULL
(	NULL
20	NULL
,	NULL
21	NULL
)	NULL
.	NULL

This	NULL
induction	NULL
takes	NULL
place	NULL
at	NULL
the	NULL
transcriptional	NULL
level	NULL
and	NULL
is	NULL
mediated	NULL
by	NULL
two	NULL
NFAT	NULL
sites	NULL
in	NULL
the	NULL
COX-2	NULL
promoter	NULL
(	NULL
21	NULL
)	NULL
.	NULL

Previous	NULL
studies	NULL
in	NULL
different	NULL
cells	NULL
types	NULL
(	NULL
including	NULL
vascular	NULL
endothelial	NULL
cells	NULL
,	NULL
lung	NULL
epithelial	NULL
cells	NULL
,	NULL
synoviocytes	NULL
,	NULL
pancreatic	NULL
cells	NULL
,	NULL
gingival	NULL
fibro-blasts	NULL
,	NULL
and	NULL
monocytes	NULL
)	NULL
have	NULL
shown	NULL
the	NULL
importance	NULL
of	NULL
NF-kB	NULL
and	NULL
AP-1	NULL
transcription	NULL
factors	NULL
in	NULL
other	NULL
cell	NULL
types	NULL
(	NULL
22-34	NULL
)	NULL
.	NULL

In	NULL
unstimulated	NULL
T	NULL
cells	NULL
NFAT	NULL
transcription	NULL
factor	NULL
is	NULL
heavily	NULL
phosphorylated	NULL
and	NULL
localized	NULL
in	NULL
the	NULL
cytosol	NULL
.	NULL

Upon	NULL
T	NULL
cell	NULL
activation	NULL
,	NULL
it	NULL
becomes	NULL
dephosphorylated	NULL
by	NULL
calcium/calcineurin	NULL
phosphatase	NULL
and	NULL
translocates	NULL
into	NULL
the	NULL
nucleus	NULL
(	NULL
for	NULL
review	NULL
,	NULL
see	NULL
Ref	NULL
.	NULL

35	NULL
)	NULL
.	NULL

Stimulation	NULL
of	NULL
T	NULL
cells	NULL
by	NULL
phorbol	NULL
esters	NULL
and	NULL
calcium	NULL
ionophore	NULL
A23187	NULL
regulates	NULL
not	NULL
only	NULL
the	NULL
nuclear	NULL
localization	NULL
of	NULL
NFAT	NULL
,	NULL
but	NULL
also	NULL
its	NULL
transactivation	NULL
activity	NULL
(	NULL
35	NULL
,	NULL
36	NULL
)	NULL
.	NULL

In	NULL
the	NULL
present	NULL
study	NULL
,	NULL
we	NULL
have	NULL
analyzed	NULL
the	NULL
regulation	NULL
of	NULL
COX-2	NULL
by	NULL
Cot	NULL
kinase	NULL
in	NULL
human	NULL
T	NULL
cells	NULL
,	NULL
showing	NULL
that	NULL
Cot	NULL
induces	NULL
transcription	NULL
of	NULL
COX-2	NULL
in	NULL
these	NULL
cells	NULL
.	NULL

Regulation	NULL
of	NULL
COX-2	NULL
expression	NULL
by	NULL
Cot	NULL
kinase	NULL
occurs	NULL
mainly	NULL
through	NULL
activation	NULL
of	NULL
NFAT	NULL
.	NULL

Both	NULL
distal	NULL
and	NULL
proximal	NULL
NFAT	NULL
response	NULL
elements	NULL
in	NULL
the	NULL
COX-2	NULL
promoter	NULL
are	NULL
essential	NULL
for	NULL
Cot	NULL
kinase-mediated	NULL
induction	NULL
.	NULL

We	NULL
also	NULL
provide	NULL
evidence	NULL
that	NULL
neither	NULL
NF-	NULL
«	NULL
B	NULL
nor	NULL
c-Jun	NULL
is	NULL
involved	NULL
in	NULL
this	NULL
activation	NULL
.	NULL

Finally	NULL
,	NULL
we	NULL
have	NULL
determined	NULL
that	NULL
Cot	NULL
kinase	NULL
increases	NULL
transactivation	NULL
mediated	NULL
by	NULL
the	NULL
N-terminal	NULL
domain	NULL
of	NULL
NFAT	NULL
.	NULL

Involvement	NULL
of	NULL
Cot	NULL
kinase-induced	NULL
NFAT	NULL
transactivation	NULL
in	NULL
the	NULL
COX-2	NULL
promoter	NULL
activation	NULL
is	NULL
discussed	NULL
further	NULL
.	NULL

EXPERIMENTAL	NULL
PROCEDURES	NULL
Plasmids-The	NULL
pEF-BOS	NULL
Cot	NULL
,	NULL
pEF-BOS	NULL
trunc-Cot	NULL
,	NULL
and	NULL
pEF-BOS	NULL
inac-Cot	NULL
have	NULL
been	NULL
described	NULL
previously	NULL
(	NULL
14	NULL
)	NULL
.	NULL

The	NULL
different	NULL
COX-2	NULL
promoter	NULL
luciferase	NULL
constructs	NULL
(	NULL
P2-1102	NULL
(	NULL
-998	NULL
to	NULL
+104	NULL
)	NULL
,	NULL
P2-625	NULL
(	NULL
-521	NULL
to	NULL
+104	NULL
)	NULL
,	NULL
P2-481	NULL
(	NULL
-827	NULL
to	NULL
+104	NULL
)	NULL
,	NULL
P2-274	NULL
(	NULL
-170	NULL
to	NULL
+104	NULL
)	NULL
,	NULL
P2-192	NULL
(	NULL
-88	NULL
*The	NULL
abbreviations	NULL
used	NULL
are	NULL
:	NULL
AP-1	NULL
,	NULL
activator	NULL
protein	NULL
1	NULL
;	NULL
NFAT	NULL
,	NULL
nuclear	NULL
factor	NULL
of	NULL
activated	NULL
T	NULL
cells	NULL
;	NULL
NF-	NULL
«	NULL
B	NULL
,	NULL
nuclear	NULL
factor	NULL
kB	NULL
;	NULL
COX	NULL
,	NULL
cyclooxygenase	NULL
;	NULL
CMV	NULL
,	NULL
cytomegalovirus	NULL
;	NULL
wt	NULL
,	NULL
wild	NULL
type	NULL
;	NULL
dn	NULL
,	NULL
dominant	NULL
negative	NULL
;	NULL
PCR	NULL
,	NULL
polymerase	NULL
chain	NULL
reaction	NULL
;	NULL
TPA	NULL
,	NULL
12-O-tetradecanoyl-phorbol-13-acetate	NULL
;	NULL
PDBu	NULL
,	NULL
phorbol	NULL
12,18-dibutyrate	NULL
;	NULL
CsA	NULL
,	NULL
cyclosporin	NULL
A	NULL
;	NULL
RLU	NULL
,	NULL
relative	NULL
light	NULL
unit	NULL
.	NULL

27008	NULL
610Z	NULL
'01	NULL
Aepy	NULL
uo	NULL
1san8	NULL
4g	NULL
/S10-aqf	NULL
/	NULL
wroj	NULL
;	NULL
27004	NULL
to	NULL
+104	NULL
)	NULL
,	NULL
P2-150	NULL
(	NULL
-46	NULL
to	NULL
104	NULL
)	NULL
,	NULL
and	NULL
P2-274	NULL
pNFAT-mut	NULL
,	NULL
P2-274	NULL
dNFAT-mut	NULL
)	NULL
as	NULL
well	NULL
as	NULL
the	NULL
P2-274	NULL
COX-2	NULL
d	NULL
&	NULL
pNFAT-mut	NULL
were	NULL
originally	NULL
described	NULL
by	NULL
Iniquez	NULL
ef	NULL
al	NULL
.	NULL

(	NULL
21	NULL
)	NULL
.	NULL

The	NULL
plasmid	NULL
P2-431	NULL
«	NULL
kB-mut	NULL
construct	NULL
with	NULL
the	NULL
NF-	NULL
«	NULL
B	NULL
site	NULL
(	NULL
located	NULL
in	NULL
-223/-214	NULL
)	NULL
of	NULL
the	NULL
human	NULL
COX-2	NULL
promoter	NULL
mutated	NULL
was	NULL
obtained	NULL
by	NULL
in	NULL
vitro	NULL
directed	NULL
mutagenesis	NULL
performed	NULL
with	NULL
the	NULL
QuikChange	NULL
site-directed	NULL
mutagenesis	NULL
kit	NULL
(	NULL
Strat-agene	NULL
)	NULL
.	NULL

Briefly	NULL
,	NULL
synthetic	NULL
oligonucleotides	NULL
containing	NULL
the	NULL
desired	NULL
mutation	NULL
and	NULL
complementary	NULL
to	NULL
opposite	NULL
strands	NULL
were	NULL
extended	NULL
by	NULL
using	NULL
the	NULL
Pfu	NULL
turbo	NULL
DNA	NULL
polymerase	NULL
,	NULL
generating	NULL
a	NULL
mutated	NULL
plasmid	NULL
.	NULL

The	NULL
sequence	NULL
of	NULL
the	NULL
COX-2	NULL
«	NULL
B	NULL
mutant	NULL
primers	NULL
were	NULL
GtacCTACCCCCTCTGCTCCC-3	NULL
(	NULL
where	NULL
lowercase	NULL
letters	NULL
indicate	NULL
the	NULL
mutated	NULL
position	NULL
in	NULL
the	NULL
NF-	NULL
«	NULL
B	NULL
site	NULL
of	NULL
the	NULL
human	NULL
COX-2	NULL
promoter	NULL
)	NULL
and	NULL
its	NULL
complementary	NULL
sequence	NULL
.	NULL

The	NULL
nucleotide	NULL
sequence	NULL
of	NULL
this	NULL
plasmid	NULL
was	NULL
confirmed	NULL
by	NULL
automatic	NULL
DNA	NULL
sequencing	NULL
.	NULL

The	NULL
plasmid	NULL
pCMV-p65	NULL
contains	NULL
the	NULL
cDNA	NULL
of	NULL
the	NULL
human	NULL
p65	NULL
NF-	NULL
«	NULL
B	NULL
protein	NULL
in	NULL
the	NULL
pCDNAS	NULL
expression	NULL
vector	NULL
and	NULL
was	NULL
a	NULL
gift	NULL
from	NULL
Dr.	NULL
Alcami	NULL
.	NULL

The	NULL
«	NULL
B	NULL
luciferase	NULL
reporter	NULL
contains	NULL
three	NULL
copies	NULL
of	NULL
the	NULL
kB	NULL
consensus	NULL
sequence	NULL
of	NULL
the	NULL
immunoglobulins	NULL
x	NULL
chain	NULL
(	NULL
87	NULL
)	NULL
.	NULL

The	NULL
full-length	NULL
human	NULL
NFAT	NULL
(	NULL
p1SH107¢	NULL
,	NULL
NFATwt	NULL
)	NULL
and	NULL
the	NULL
dominant	NULL
negative	NULL
NFATe	NULL
(	NULL
p1SH102CAA418	NULL
,	NULL
dnNFAT	NULL
)	NULL
expression	NULL
plasmids	NULL
were	NULL
generously	NULL
provided	NULL
by	NULL
Dr.	NULL
Crabtree	NULL
(	NULL
88	NULL
)	NULL
.	NULL

The	NULL
ACAM-AI	NULL
plasmid	NULL
encoding	NULL
a	NULL
deletion	NULL
mutant	NULL
of	NULL
a	NULL
calcineurin	NULL
catalytic	NULL
subunit	NULL
has	NULL
been	NULL
described	NULL
previously	NULL
(	NULL
89	NULL
)	NULL
.	NULL

The	NULL
pCMV-TAM67	NULL
plasmid	NULL
encoding	NULL
a	NULL
dominant	NULL
negative	NULL
mutant	NULL
variant	NULL
of	NULL
c-Jun	NULL
and	NULL
the	NULL
plasmid	NULL
pRSV	NULL
c-Jun	NULL
encoding	NULL
the	NULL
wild	NULL
type	NULL
c-Jun	NULL
(	NULL
c-Junwt	NULL
)	NULL
were	NULL
a	NULL
gift	NULL
from	NULL
Balduino	NULL
Burgering	NULL
.	NULL

The	NULL
vector	NULL
trunc-Cot	NULL
-	NULL
TPA+lon	NULL
=-	NULL
TPA+lon	NULL
CAPDY	NULL
Fic	NULL
.	NULL

1	NULL
.	NULL

Cot	NULL
kinase	NULL
activity	NULL
induces	NULL
COX-2	NULL
mRNA	NULL
levels	NULL
in	NULL
Jurkat	NULL
cells	NULL
.	NULL

Total	NULL
RNA	NULL
from	NULL
Jurkat	NULL
cells	NULL
electroporated	NULL
with	NULL
10	NULL
ug/ml	NULL
pEF-BOS	NULL
trunc-Cot	NULL
or	NULL
10	NULL
ug/ml	NULL
pEF-BOS	NULL
stimulated	NULL
or	NULL
not	NULL
with	NULL
1	NULL
uM	NULL
calcium	NULL
ionophore	NULL
(	NULL
Zon	NULL
)	NULL
and	NULL
15	NULL
ng/ml	NULL
TPA	NULL
,	NULL
was	NULL
used	NULL
for	NULL
reverse	NULL
transcription-PCR	NULL
analysis	NULL
to	NULL
measure	NULL
COX-2	NULL
and	NULL
glyceraldehyde-3-phosphate	NULL
dehydrogenase	NULL
(	NULL
GAPDH	NULL
)	NULL
mRNA	NULL
levels	NULL
.	NULL

Amplified	NULL
cDNA	NULL
fragments	NULL
were	NULL
separated	NULL
by	NULL
agarose	NULL
gel	NULL
electrophoresis	NULL
,	NULL
and	NULL
bands	NULL
were	NULL
visualized	NULL
by	NULL
ethidium	NULL
bromide	NULL
staining	NULL
.	NULL

Data	NULL
shown	NULL
correspond	NULL
to	NULL
a	NULL
number	NULL
of	NULL
cycles	NULL
in	NULL
which	NULL
the	NULL
amount	NULL
of	NULL
amplified	NULL
product	NULL
is	NULL
proportional	NULL
to	NULL
the	NULL
abundance	NULL
of	NULL
starting	NULL
material	NULL
.	NULL

The	NULL
figure	NULL
shows	NULL
one	NULL
of	NULL
the	NULL
three	NULL
experiments	NULL
performed	NULL
.	NULL

Transcriptional	NULL
Activation	NULL
of	NULL
Cyclooxygenase-2	NULL
by	NULL
Cot	NULL
Kinase	NULL
GAL4-hNFAT1	NULL
(	NULL
1-415	NULL
)	NULL
contains	NULL
the	NULL
first	NULL
415	NULL
amino	NULL
acids	NULL
of	NULL
the	NULL
human	NULL
NFAT1l/p	NULL
fused	NULL
to	NULL
the	NULL
DNA	NULL
binding	NULL
domain	NULL
of	NULL
the	NULL
yeast	NULL
GALA	NULL
transcription	NULL
factor	NULL
(	NULL
amino	NULL
acids	NULL
1-147	NULL
)	NULL
.	NULL

This	NULL
plasmid	NULL
was	NULL
constructed	NULL
by	NULL
subcloning	NULL
a	NULL
PCR	NULL
fragment	NULL
of	NULL
the	NULL
hNFAT1	NULL
(	NULL
40	NULL
)	NULL
into	NULL
the	NULL
pABGAL-linker	NULL
plasmid	NULL
(	NULL
41	NULL
)	NULL
digested	NULL
with	NULL
Xhol	NULL
.	NULL

The	NULL
5'-primer	NULL
used	NULL
was	NULL
GGetc-gagATGAACGCCCCCGAGCGGCAGC	NULL
;	NULL
the	NULL
3'-primer	NULL
,	NULL
CCCgtcegacT-TACTGCACCTCGATCCGCAGCTCG	NULL
,	NULL
contains	NULL
a	NULL
Sa/l	NULL
site	NULL
(	NULL
lowercase	NULL
letters	NULL
)	NULL
.	NULL

The	NULL
sequence	NULL
was	NULL
confirmed	NULL
by	NULL
automatic	NULL
sequencing	NULL
.	NULL

The	NULL
GAL4-DBD	NULL
is	NULL
the	NULL
parental	NULL
vector	NULL
pABGAL-linker	NULL
plasmid	NULL
.	NULL

The	NULL
GAL4-luciferase	NULL
reporter	NULL
plasmid	NULL
includes	NULL
five	NULL
copies	NULL
of	NULL
GAL4	NULL
DNA	NULL
binding	NULL
sites	NULL
fused	NULL
to	NULL
the	NULL
luciferase	NULL
gene	NULL
(	NULL
42	NULL
)	NULL
.	NULL

Reverse	NULL
Transcription-PCR	NULL
Assay-The	NULL
human	NULL
leukemia	NULL
T	NULL
cell	NULL
line	NULL
Jurkat	NULL
was	NULL
maintained	NULL
in	NULL
RPMI	NULL
1640	NULL
medium	NULL
supplemented	NULL
with	NULL
10	NULL
%	NULL
fetal	NULL
calf	NULL
serum	NULL
(	NULL
Life	NULL
Technologies	NULL
,	NULL
Inc.	NULL
)	NULL
,	NULL
50	NULL
ug/ml	NULL
gentamycin	NULL
,	NULL
and	NULL
2	NULL
mM	NULL
L-glutamine	NULL
(	NULL
complete	NULL
medium	NULL
)	NULL
.	NULL

Jurkat	NULL
cells	NULL
were	NULL
electroporated	NULL
with	NULL
10	NULL
ug/ml	NULL
pEF-BOS	NULL
or	NULL
pEF-BOS	NULL
trunc-Cot	NULL
as	NULL
described	NULL
by	NULL
Ballester	NULL
ef	NULL
al	NULL
.	NULL

(	NULL
14	NULL
)	NULL
.	NULL

In	NULL
these	NULL
conditions	NULL
the	NULL
electroporation	NULL
efficiency	NULL
,	NULL
as	NULL
tested	NULL
by	NULL
green	NULL
fluorescence	NULL
protein	NULL
expression	NULL
,	NULL
was	NULL
about	NULL
30-40	NULL
%	NULL
.	NULL

80	NULL
min	NULL
after	NULL
electroporation	NULL
,	NULL
transfected	NULL
cells	NULL
were	NULL
stimulated	NULL
overnight	NULL
with	NULL
1	NULL
pM	NULL
calcium	NULL
ionophore	NULL
and	NULL
15	NULL
ng/ml	NULL
TPA	NULL
,	NULL
and	NULL
total	NULL
RNA	NULL
was	NULL
extracted	NULL
using	NULL
the	NULL
TRIzol	NULL
protocol	NULL
(	NULL
Life	NULL
Technologies	NULL
,	NULL
Inc.	NULL
)	NULL
.	NULL

1	NULL
ug	NULL
of	NULL
total	NULL
RNA	NULL
from	NULL
control	NULL
or	NULL
stimulated	NULL
cells	NULL
was	NULL
used	NULL
to	NULL
perform	NULL
the	NULL
reverse	NULL
transcription	NULL
reaction	NULL
.	NULL

The	NULL
specific	NULL
primers	NULL
for	NULL
either	NULL
human	NULL
COX-2	NULL
or	NULL
glyceraldehyde-3-phosphate	NULL
dehydrogenase	NULL
for	NULL
PCR	NULL
amplification	NULL
has	NULL
been	NULL
described	NULL
previously	NULL
(	NULL
20	NULL
)	NULL
.	NULL

The	NULL
PCR	NULL
was	NULL
amplified	NULL
20-35	NULL
denaturation	NULL
cycles	NULL
at	NULL
94	NULL
°C	NULL
for	NULL
1	NULL
min	NULL
,	NULL
annealing	NULL
at	NULL
60	NULL
°C	NULL
for	NULL
1	NULL
min	NULL
,	NULL
and	NULL
extension	NULL
at	NULL
72	NULL
°C	NULL
for	NULL
1	NULL
min	NULL
.	NULL

Amplified	NULL
cDNA	NULL
fragments	NULL
were	NULL
separated	NULL
by	NULL
agarose	NULL
gel	NULL
electrophoresis	NULL
,	NULL
and	NULL
bands	NULL
were	NULL
visualized	NULL
by	NULL
ethidium	NULL
bromide	NULL
staining	NULL
.	NULL

Promoter-driven	NULL
Transcription	NULL
and	NULL
Transactivation	NULL
Assays-Jurkat	NULL
cells	NULL
were	NULL
cotransfected	NULL
unless	NULL
otherwise	NULL
indicated	NULL
,	NULL
with	NULL
0.75	NULL
ug/ml	NULL
of	NULL
different	NULL
COX-2	NULL
promoter-luciferase	NULL
reporter	NULL
constructs	NULL
together	NULL
with	NULL
0.35	NULL
ug/ml	NULL
pEF-BOS	NULL
,	NULL
pEF-BOS	NULL
Cot	NULL
,	NULL
pEF-BOS	NULL
trunc-Cot	NULL
,	NULL
or	NULL
pEF-BOS	NULL
inac-Cot	NULL
constructs	NULL
utilizing	NULL
Lipofectin	NULL
reagent	NULL
(	NULL
Life	NULL
Technologies	NULL
,	NULL
Inc.	NULL
)	NULL
,	NULL
according	NULL
to	NULL
the	NULL
manufacturer	NULL
's	NULL
instructions	NULL
.	NULL

All	NULL
transfections	NULL
were	NULL
normalized	NULL
to	NULL
the	NULL
same	NULL
amount	NULL
of	NULL
DNA	NULL
.	NULL

20	NULL
h	NULL
after	NULL
transfection	NULL
,	NULL
cells	NULL
were	NULL
stimulated	NULL
with	NULL
10	NULL
pg/ml	NULL
soluble	NULL
a-CD3	NULL
,	NULL
isolated	NULL
as	NULL
described	NULL
by	NULL
Ballester	NULL
et	NULL
al	NULL
.	NULL

(	NULL
13	NULL
)	NULL
;	NULL
1	NULL
pg/ml	NULL
soluble	NULL
«	NULL
-CD28	NULL
(	NULL
9.3	NULL
antibody	NULL
,	NULL
generously	NULL
donated	NULL
by	NULL
Dr.	NULL
C.	NULL
June	NULL
)	NULL
;	NULL
1	NULL
uM	NULL
calcium	NULL
ionophore	NULL
A283187	NULL
(	NULL
Sigma	NULL
)	NULL
,	NULL
in	NULL
the	NULL
presence	NULL
or	NULL
absence	NULL
of	NULL
phorbol	NULL
esters	NULL
(	NULL
50	NULL
ng/ml	NULL
PDBu	NULL
(	NULL
Sigma	NULL
)	NULL
or	NULL
15	NULL
ng/ml	NULL
TPA	NULL
(	NULL
Sigma	NULL
)	NULL
.	NULL

Cyclosporin	NULL
A	NULL
(	NULL
CsA	NULL
,	NULL
100	NULL
ng/ml	NULL
,	NULL
Sandoz	NULL
)	NULL
was	NULL
added	NULL
to	NULL
the	NULL
cells	NULL
1	NULL
h	NULL
before	NULL
stimulation	NULL
.	NULL

Cells	NULL
were	NULL
collected	NULL
by	NULL
centrifugation	NULL
,	NULL
and	NULL
luciferase	NULL
activity	NULL
was	NULL
determined	NULL
by	NULL
the	NULL
luciferase	NULL
assay	NULL
kit	NULL
(	NULL
Promega	NULL
)	NULL
,	NULL
according	NULL
to	NULL
the	NULL
manufacturer	NULL
's	NULL
instructions	NULL
.	NULL

For	NULL
transactivation	NULL
assays	NULL
,	NULL
Jurkat	NULL
cells	NULL
were	NULL
cotransfected	NULL
with	NULL
0.3	NULL
ug/ml	NULL
GAL4-DBD	NULL
or	NULL
GAL4-hNFAT1	NULL
(	NULL
1-415	NULL
)	NULL
expression	NULL
vector	NULL
and	NULL
0.5	NULL
ug/ml	NULL
GALA	NULL
luciferase	NULL
reporter	NULL
plasmid	NULL
together	NULL
with	NULL
0.35	NULL
ug/ml	NULL
of	NULL
the	NULL
different	NULL
pEF-BOS	NULL
constructs	NULL
.	NULL

Transfected	NULL
cells	NULL
were	NULL
stimulated	NULL
or	NULL
not	NULL
as	NULL
indicated	NULL
above	NULL
,	NULL
and	NULL
luciferase	NULL
activity	NULL
was	NULL
measured	NULL
after	NULL
48	NULL
h.	NULL
Protein	NULL
measurements	NULL
were	NULL
performed	NULL
with	NULL
the	NULL
D	NULL
,	NULL
,	NULL
protein	NULL
assay	NULL
(	NULL
Bio-Rad	NULL
)	NULL
.	NULL

B	NULL
Fig	NULL
.	NULL

2	NULL
.	NULL

Regulation	NULL
of	NULL
COX-2	NULL
promoter-driven	NULL
transcription	NULL
by	NULL
Cot	NULL
kinase	NULL
activity	NULL
.	NULL

Panel	NULL
A	NULL
,	NULL
Jurkat	NULL
cells	NULL
were	NULL
cotransfected	NULL
with	NULL
0.75	NULL
ug/ml	NULL
P2-1102	NULL
lucif-	NULL
5	NULL
erase	NULL
together	NULL
with	NULL
0.35	NULL
pg/ml	NULL
pEF-BOS	NULL
trunc-Cot	NULL
,	NULL
pEF-BOS	NULL
Cot	NULL
,	NULL
or	NULL
pEF-BOS	NULL
;	NULL
after	NULL
48	NULL
h	NULL
luciferase	NULL
activity	NULL
was	NULL
measured	NULL
.	NULL

The	NULL
figure	NULL
shows	NULL
the	NULL
mean	NULL
of	NULL
fold	NULL
induction	NULL
of	NULL
two	NULL
different	NULL
experiments	NULL
performed	NULL
in	NULL
duplicate	NULL
*	NULL
S.D	NULL
.	NULL

Panel	NULL
B	NULL
,	NULL
Jurkat	NULL
T	NULL
cells	NULL
transfected	NULL
with	NULL
0.75	NULL
pg/ml	NULL
P2-1102	NULL
luciferase	NULL
together	NULL
with	NULL
0.35	NULL
ug/ml	NULL
pEF-BOS	NULL
or	NULL
0.35	NULL
or	NULL
0.11	NULL
ug/ml	NULL
pEF-BOS	NULL
inac-Cot	NULL
were	NULL
subjected	NULL
to	NULL
stimulation	NULL
with	NULL
1	NULL
pg/ml	NULL
«	NULL
-CD28	NULL
and	NULL
10	NULL
2	NULL
ug/ml	NULL
e-€CD3	NULL
,	NULL
or	NULL
with	NULL
50	NULL
ng/ml	NULL
PDBu	NULL
(	NULL
PDB	NULL
)	NULL
and	NULL
1	NULL
uM	NULL
calcium	NULL
ionophore	NULL
(	NULL
Jon	NULL
)	NULL
,	NULL
and	NULL
activity	NULL
was	NULL
measured	NULL
.	NULL

The	NULL
figure	NULL
A	NULL
shows	NULL
the	NULL
mean	NULL
of	NULL
RLU	NULL
values/mg	NULL
of	NULL
protein	NULL
+	NULL
S.D	NULL
.	NULL

of	NULL
three	NULL
different	NULL
experiments	NULL
performed	NULL
in	NULL
triplicate	NULL
.	NULL

Fold	NULL
induction	NULL
to	NULL
vector	NULL
p2-1102	NULL
so	NULL
M	NULL
vector	NULL
(	NULL
0.35ug/m	NULL
!	NULL
)	NULL

M	NULL
inac-Cot	NULL
(	NULL
0.11ug/ml	NULL
)	NULL
Q	NULL
inac-Cot	NULL
(	NULL
0.35	NULL
ug/m	NULL
!	NULL
)	NULL

|	NULL
2	NULL
RLUs	NULL
(	NULL
103	NULL
)	NULL
3	NULL
Cot	NULL
trunc-Cot	NULL
PDB+lon	NULL
-	NULL
«	NULL
-CD28	NULL
+	NULL
«	NULL
-CD3	NULL
610Z	NULL
'01	NULL
Aepy	NULL
uo	NULL
1san8	NULL
4g	NULL
/S10-aqf	NULL
/	NULL
wroj	NULL
;	NULL
Transcriptional	NULL
Activation	NULL
of	NULL
Cyclooxygenase-2	NULL
by	NULL
Cot	NULL
Kinase	NULL
27005	NULL
25	NULL
No	NULL
addition	NULL
_	NULL
[	NULL
O	NULL
vector	NULL
PDB	NULL
+	NULL
lon	NULL
_	NULL
[	NULL
O	NULL
vector	NULL
E	NULL
trunc-Cot	NULL
®	NULL
trunc-Cot	NULL
Fic	NULL
.	NULL

3	NULL
.	NULL

Cot	NULL
kinase	NULL
regulation	NULL
of	NULL
COX-2	NULL
promoter	NULL
constructs	NULL
in	NULL
Jurkat	NULL
200	NULL
)	NULL
cells	NULL
.	NULL

Jurkat	NULL
cells	NULL
were	NULL
transfected	NULL
with	NULL
0.75	NULL
ug/ml	NULL
of	NULL
different	NULL
COX-2	NULL
promoter	NULL
150	NULL
constructs	NULL
(	NULL
P2-1102	NULL
,	NULL
P2-626	NULL
,	NULL
P2-431	NULL
,	NULL
P2-274	NULL
,	NULL
P2-192	NULL
,	NULL
P2-150	NULL
)	NULL
together	NULL
with	NULL
0.85	NULL
ug/ml	NULL
pEF-BOS	NULL
trunc-Cot	NULL
or	NULL
pEF-BOS	NULL
.	NULL

Transfected	NULL
cells	NULL
were	NULL
stimulated	NULL
or	NULL
not	NULL
100	NULL
with	NULL
50	NULL
ng/ml	NULL
PDBu	NULL
(	NULL
PDB	NULL
)	NULL
and	NULL
1	NULL
uM	NULL
cal	NULL
cium	NULL
ionophore	NULL
(	NULL
Zor	NULL
)	NULL
.	NULL

The	NULL
graph	NULL
shows	NULL
the	NULL
mean	NULL
of	NULL
the	NULL
RLU	NULL
values	NULL
of	NULL
three	NULL
dif-	NULL
50	NULL
ferent	NULL
experiments	NULL
+	NULL
S.D	NULL
.	NULL

RLUs	NULL
(	NULL
109	NULL
|_I	NULL
0p2-1	NULL
102	NULL
p2-626	NULL
p2-431	NULL
p2-274	NULL
p2-192	NULL
p2-150p2-1102p2-626p2-431	NULL
p2-274	NULL
p2-192	NULL
p2-150	NULL
No	NULL
addition	NULL
PDB	NULL
+	NULL
lOn	NULL
|	NULL
n	NULL
vector	NULL
400	NULL
7	NULL
a	NULL
trunc-Cot|	NULL
F2000	NULL
300	NULL
7	NULL
200	NULL
7	NULL
RLUs	NULL
(	NULL
103	NULL
)	NULL
100	NULL
9	NULL
``	NULL
~	NULL
po-431-kBmut	NULL
p	NULL
?	NULL

-274	NULL
200	NULL
If	NULL
g	NULL
vector	NULL
#	NULL
CMV-pé5	NULL
1604	NULL
1204	NULL
RLUs	NULL
(	NULL
103	NULL
)	NULL
&	NULL
O	NULL
40	NULL
4	NULL
kB-Luc	NULL
p2-431	NULL
p2-274	NULL
RESULTS	NULL
Cot	NULL
Kinase	NULL
Up-regulates	NULL
COX-2	NULL
Gene	NULL
Expression	NULL
and	NULL
COX-2	NULL
Promoter	NULL
Activity-We	NULL
have	NULL
reported	NULL
previously	NULL
that	NULL
T	NULL
cell	NULL
activation	NULL
induced	NULL
by	NULL
phorbol	NULL
esters	NULL
plus	NULL
calcium	NULL
ionophore	NULL
,	NULL
or	NULL
a	NULL
«	NULL
-CD3	NULL
plus	NULL
a-CD28	NULL
,	NULL
increases	NULL
COX-2	NULL
mRNA	NULL
levels	NULL
in	NULL
primary	NULL
resting	NULL
human	NULL
T	NULL
lymphocytes	NULL
as	NULL
well	NULL
as	NULL
in	NULL
Jurkat	NULL
T	NULL
cells	NULL
(	NULL
20	NULL
,	NULL
21	NULL
)	NULL
.	NULL

In	NULL
agreement	NULL
with	NULL
these	NULL
data	NULL
,	NULL
COX-2	NULL
mRNA	NULL
was	NULL
increased	NULL
in	NULL
Jurkat	NULL
cells	NULL
transfected	NULL
with	NULL
the	NULL
empty	NULL
pEF-BOS	NULL
vector	NULL
upon	NULL
treatment	NULL
with	NULL
calcium	NULL
ionophore	NULL
plus	NULL
TPA	NULL
(	NULL
Fig	NULL
.	NULL

1	NULL
)	NULL
.	NULL

Interestingly	NULL
,	NULL
cotransfection	NULL
of	NULL
Jurkat	NULL
cells	NULL
with	NULL
an	NULL
active	NULL
form	NULL
of	NULL
Cot	NULL
kinase	NULL
(	NULL
pEF-BOS	NULL
trunc-Cot	NULL
)	NULL
increased	NULL
the	NULL
levels	NULL
of	NULL
COX-2	NULL
transcript	NULL
.	NULL

Thus	NULL
,	NULL
overexpression	NULL
of	NULL
truncated	NULL
Cot	NULL
kinase	NULL
was	NULL
sufficient	NULL
to	NULL
detect	NULL
increased	NULL
levels	NULL
of	NULL
COX-2	NULL
tran-scripts	NULL
,	NULL
although	NULL
maximal	NULL
induction	NULL
was	NULL
observed	NULL
in	NULL
cells	NULL
over-expressing	NULL
Cot	NULL
kinase	NULL
upon	NULL
calcium	NULL
ionophore	NULL
plus	NULL
TPA	NULL
stimulation	NULL
(	NULL
Fig	NULL
.	NULL

1	NULL
)	NULL
.	NULL

p2-431	NULL
p2-431-kBmut	NULL
-	NULL
p2-274	NULL
F1500	NULL
RLUs	NULL
(	NULL
103	NULL
)	NULL
-1000	NULL
Fig	NULL
.	NULL

4	NULL
.	NULL

Role	NULL
of	NULL
the	NULL
NF-	NULL
transcription	NULL
factor	NULL
activity	NULL
in	NULL
the	NULL
COX-2	NULL
pro-L	NULL
500	NULL
moter	NULL
activation	NULL
in	NULL
Jurkat	NULL
T	NULL
cells	NULL
.	NULL

Panel	NULL
A	NULL
,	NULL
Jurkat	NULL
cells	NULL
were	NULL
transfected	NULL
with	NULL
0.75	NULL
ug/ml	NULL
of	NULL
the	NULL
P2-481	NULL
,	NULL
P2-481	NULL
«	NULL
B-mut	NULL
,	NULL
or	NULL
P2-274	NULL
COX-2	NULL
promoter	NULL
constructs	NULL
together	NULL
with	NULL
0.85	NULL
ug/ml	NULL
pEF-BOS	NULL
trunc-Cot	NULL
or	NULL
0.35	NULL
ug/ml	NULL
pEF-BOS	NULL
,	NULL
and	NULL
luciferase	NULL
activity	NULL
was	NULL
measured	NULL
.	NULL

Transfected	NULL
cells	NULL
were	NULL
stimulated	NULL
or	NULL
not	NULL
with	NULL
50	NULL
ng/ml	NULL
PDBu	NULL
(	NULL
PDB	NULL
)	NULL
and	NULL
1	NULL
uM	NULL
calcium	NULL
ionophore	NULL
(	NULL
Zon	NULL
)	NULL
.	NULL

Panel	NULL
B	NULL
,	NULL
Jurkat	NULL
cells	NULL
were	NULL
transfected	NULL
with	NULL
0.35	NULL
ug/ml	NULL
pCMV-p65	NULL
NF-	NULL
«	NULL
B	NULL
expression	NULL
vector	NULL
together	NULL
with	NULL
0.75	NULL
ug/ml	NULL
P2-481	NULL
,	NULL
P2-274	NULL
,	NULL
or	NULL
p3x-	NULL
«	NULL
B	NULL
luciferase	NULL
reporter	NULL
plasmid	NULL
.	NULL

The	NULL
graph	NULL
shows	NULL
the	NULL
mean	NULL
of	NULL
RLU	NULL
values	NULL
of	NULL
two	NULL
different	NULL
experiments	NULL
performed	NULL
in	NULL
duplicate	NULL
+	NULL
S.D	NULL
.	NULL

To	NULL
analyze	NULL
if	NULL
Cox-2	NULL
mRNA	NULL
induction	NULL
by	NULL
Cot	NULL
kinase	NULL
correlated	NULL
with	NULL
an	NULL
increase	NULL
in	NULL
the	NULL
transcriptional	NULL
activity	NULL
mediated	NULL
by	NULL
the	NULL
COX-2	NULL
promoter	NULL
,	NULL
Jurkat	NULL
cells	NULL
were	NULL
cotransfected	NULL
with	NULL
different	NULL
COX-2	NULL
promoter	NULL
luciferase	NULL
constructs	NULL
and	NULL
expression	NULL
vectors	NULL
for	NULL
wild	NULL
type	NULL
or	NULL
truncated	NULL
Cot	NULL
kinase	NULL
.	NULL

In	NULL
agreement	NULL
with	NULL
the	NULL
regulation	NULL
of	NULL
COX-2	NULL
mRNA	NULL
levels	NULL
by	NULL
Cot	NULL
kinase	NULL
activity	NULL
,	NULL
expression	NULL
of	NULL
truncated	NULL
Cot	NULL
kinase	NULL
strongly	NULL
increased	NULL
transcription	NULL
driven	NULL
by	NULL
a	NULL
construct	NULL
spanning	NULL
from	NULL
-998	NULL
to	NULL
+	NULL
104	NULL
base	NULL
pairs	NULL
of	NULL
the	NULL
COX-2	NULL
promoter	NULL
(	NULL
P2-1102	NULL
)	NULL
(	NULL
Fig	NULL
.	NULL

24	NULL
)	NULL
.	NULL

Overexpression	NULL
of	NULL
wild	NULL
type	NULL
Cot	NULL
kinase	NULL
also	NULL
up-regulated	NULL
COX-2	NULL
promoter	NULL
activity	NULL
although	NULL
to	NULL
a	NULL
slightly	NULL
lower	NULL
extent	NULL
than	NULL
constitutively	NULL
active	NULL
truncated	NULL
Cot	NULL
kinase	NULL
(	NULL
Fig	NULL
.	NULL

24	NULL
)	NULL
.	NULL

We	NULL
next	NULL
decided	NULL
to	NULL
investigate	NULL
whether	NULL
COX-2	NULL
promoter	NULL
activation	NULL
after	NULL
T	NULL
cell	NULL
stimulation	NULL
requires	NULL
endogenous	NULL
Cot	NULL
kinase	NULL
.	NULL

For	NULL
this	NULL
,	NULL
Jurkat	NULL
cells	NULL
were	NULL
transfected	NULL
with	NULL
the	NULL
P2-1102	NULL
construct	NULL
together	NULL
with	NULL
an	NULL
inactive	NULL
form	NULL
of	NULL
Cot	NULL
kinase	NULL
(	NULL
pEF-BOS	NULL
inac-	NULL
610Z	NULL
'01	NULL
Aepy	NULL
uo	NULL
1san8	NULL
4g	NULL
/S10-aqf	NULL
/	NULL
wroj	NULL
;	NULL
27006	NULL
A	NULL
Transcriptional	NULL
Activation	NULL
of	NULL
Cyclooxygenase-2	NULL
by	NULL
Cot	NULL
Kinase	NULL
dNFat	NULL
CRE	NULL
EUC	NULL
]	NULL
NFA4L6	NULL
_	NULL
pNFAT	NULL
TATA	NULL
P2-	NULL
274	NULL
Fic	NULL
.	NULL

5	NULL
.	NULL

The	NULL
NFAT	NULL
sites	NULL
of	NULL
COX-2	NULL
promoter	NULL
are	NULL
essential	NULL
for	NULL
Cot	NULL
kinase-mediated	NULL
induction	NULL
.	NULL

Panel	NULL
A	NULL
,	NULL
Jurkat	NULL
cells	NULL
were	NULL
transfected	NULL
with	NULL
0.75	NULL
pg/ml	NULL
P2-274	NULL
,	NULL
P2-274	NULL
dNFAT-mut	NULL
,	NULL
P2-274	NULL
pNFAT-mut	NULL
,	NULL
or	NULL
P2-274	NULL
d	NULL
&	NULL
pNFAT-mut	NULL
luciferase	NULL
construct	NULL
together	NULL
with	NULL
0.35	NULL
ug/ml	NULL
pEF-BOS	NULL
trunc-Cot	NULL
or	NULL
pEF-BOS	NULL
,	NULL
and	NULL
lucifer	NULL
ase	NULL
activity	NULL
was	NULL
measured	NULL
.	NULL

Values	NULL
are	NULL
P2-	NULL
274	NULL
dNFAT-	NULL
MVT	NULL
_-	NULL
--	NULL
-J-y-§K-p	NULL
CI	NULL
P2-	NULL
274	NULL
pNFAT-	NULL
MUT	NULL
_	NULL
-J-	NULL
yg	NULL
:	NULL
--	NULL
>	NULL
*tg	NULL
P2-	NULL
274	NULL
d	NULL
&	NULL
pNFAT-MUT	NULL
--	NULL
-§-y~CR	NULL
p	NULL
]	NULL
vector	NULL
shown	NULL
as	NULL
RLUs	NULL
of	NULL
two	NULL
experiments	NULL
per-	NULL
p	NULL
trunc.COT	NULL
formed	NULL
in	NULL
duplicate	NULL
or	NULL
as	NULL
the	NULL
fold	NULL
induc-	NULL
r	NULL
--	NULL
--	NULL
r	NULL
3	NULL
tion	NULL
given	NULL
the	NULL
value	NULL
of	NULL
1	NULL
to	NULL
the	NULL
different	NULL
o	NULL
20	NULL
40	NULL
60	NULL
80	NULL
100	NULL
120	NULL
0	NULL
1	NULL
200	NULL
8	NULL
4	NULL
P2-274	NULL
COX-2	NULL
luciferase	NULL
constructs	NULL
co-	NULL
B	NULL
ARLU	NULL
(	NULL
10®	NULL
)	NULL
Fold	NULL
induction	NULL
transfected	NULL
with	NULL
pEF-BOS	NULL
.	NULL

Panel	NULL
B	NULL
,	NULL
Jurkat	NULL
cells	NULL
were	NULL
transfected	NULL
with	NULL
the	NULL
differ-	NULL
000	NULL
ent	NULL
constructs	NULL
described	NULL
in	NULL
panel	NULL
A	NULL
t	NULL
Control	NULL
together	NULL
with	NULL
0.35	NULL
ug/ml	NULL
of	NULL
expression	NULL
2500	NULL
-	NULL
®	NULL
PDB+ion	NULL
vectors	NULL
for	NULL
dnNFAT	NULL
or	NULL
NFATwt	NULL
.	NULL

Transfected	NULL
cells	NULL
were	NULL
stimulated	NULL
or	NULL
not	NULL
with	NULL
50	NULL
&	NULL
)	NULL
2000	NULL
+	NULL
ng/ml	NULL
PDBu	NULL
(	NULL
PDB	NULL
)	NULL
and	NULL
1	NULL
uM	NULL
calcium	NULL
iono-	NULL
g	NULL
phore	NULL
(	NULL
Zon	NULL
)	NULL
.	NULL

The	NULL
graph	NULL
shows	NULL
the	NULL
means	NULL
of	NULL
go	NULL
1500	NULL
¢	NULL
relative	NULL
units	NULL
of	NULL
two	NULL
different	NULL
experiments	NULL
4	NULL
performed	NULL
in	NULL
duplicate	NULL
+	NULL
S.D	NULL
.	NULL

1000	NULL
o	NULL
4	NULL
p2-274	NULL
+	NULL
+	NULL
+	NULL
+	NULL
+	NULL
+	NULL
trunc-Cot	NULL
-	NULL
+	NULL
+	NULL
+	NULL
NFATWt	NULL
-	NULL
+	NULL
+	NULL
NFATdn	NULL
~	NULL
+	NULL
+	NULL
Cot	NULL
)	NULL
and	NULL
stimulated	NULL
with	NULL
PDBu	NULL
plus	NULL
calcium	NULL
ionophore	NULL
,	NULL
or	NULL
with	NULL
a	NULL
«	NULL
-CD3	NULL
plus	NULL
«	NULL
-CD28	NULL
.	NULL

Cotransfection	NULL
of	NULL
0.35	NULL
ug/ml	NULL
or	NULL
0.11	NULL
ug/ml	NULL
of	NULL
the	NULL
pEF-BOS	NULL
inac-Cot	NULL
construct	NULL
blocked	NULL
activation	NULL
of	NULL
the	NULL
COX-2	NULL
promoter-driven	NULL
transcription	NULL
triggered	NULL
by	NULL
«	NULL
-CD3	NULL
plus	NULL
«	NULL
-CD28	NULL
(	NULL
Fig	NULL
.	NULL

2B	NULL
)	NULL
.	NULL

Treatment	NULL
with	NULL
PDBu	NULL
plus	NULL
calcium	NULL
ionophore	NULL
induced	NULL
a	NULL
higher	NULL
stimulation	NULL
of	NULL
the	NULL
COX-2	NULL
promoter-driven	NULL
transcription	NULL
,	NULL
and	NULL
consequently	NULL
a	NULL
higher	NULL
concentration	NULL
(	NULL
0.35	NULL
ug/ml	NULL
)	NULL
of	NULL
pEF-BOS	NULL
inac-Cot	NULL
was	NULL
required	NULL
to	NULL
abolish	NULL
this	NULL
induction	NULL
(	NULL
Fig	NULL
.	NULL

2B	NULL
)	NULL
.	NULL

To	NULL
identify	NULL
the	NULL
minimal	NULL
region	NULL
in	NULL
the	NULL
COX-2	NULL
promoter	NULL
responsible	NULL
for	NULL
Cot	NULL
kinase-mediated	NULL
activation	NULL
,	NULL
Jurkat	NULL
T	NULL
cells	NULL
were	NULL
cotransfected	NULL
with	NULL
different	NULL
deletions	NULL
of	NULL
the	NULL
COX-2	NULL
promoter	NULL
(	NULL
P2-1102	NULL
,	NULL
P2-626	NULL
,	NULL
P2-431	NULL
,	NULL
P2-274	NULL
,	NULL
P2-192	NULL
,	NULL
and	NULL
P2-150	NULL
)	NULL
together	NULL
with	NULL
pEF-BOS	NULL
trunc-Cot	NULL
.	NULL

Deletion	NULL
up	NULL
to	NULL
-170	NULL
in	NULL
the	NULL
P2-274	NULL
construct	NULL
did	NULL
not	NULL
significantly	NULL
affect	NULL
activation	NULL
of	NULL
COX-2	NULL
promoter	NULL
activity	NULL
by	NULL
Cot	NULL
.	NULL

Thus	NULL
,	NULL
Cot	NULL
kinase	NULL
increased	NULL
about	NULL
6-10-fold	NULL
the	NULL
transcription	NULL
driven	NULL
by	NULL
P2-1103	NULL
,	NULL
P2-626	NULL
,	NULL
P2-431	NULL
,	NULL
and	NULL
P2-274	NULL
COX-2	NULL
promoter	NULL
constructs	NULL
(	NULL
Fig	NULL
.	NULL

3	NULL
)	NULL
.	NULL

However	NULL
,	NULL
deletion	NULL
of	NULL
the	NULL
-170	NULL
to	NULL
-88	NULL
region	NULL
of	NULL
the	NULL
COX-2	NULL
promoter	NULL
(	NULL
P2-192	NULL
)	NULL
decreased	NULL
the	NULL
capacity	NULL
of	NULL
truncated	NULL
Cot	NULL
kinase	NULL
to	NULL
induce	NULL
COX-2	NULL
transcription	NULL
,	NULL
and	NULL
only	NULL
a	NULL
3-fold	NULL
activation	NULL
was	NULL
observed	NULL
.	NULL

Further	NULL
deletion	NULL
up	NULL
to	NULL
-46	NULL
(	NULL
P2-150	NULL
)	NULL
abrogated	NULL
COX-2	NULL
inducibility	NULL
by	NULL
Cot	NULL
kinase	NULL
.	NULL

The	NULL
pXP2	NULL
vector	NULL
showed	NULL
no	NULL
activation	NULL
when	NULL
cotransfected	NULL
with	NULL
truncated	NULL
Cot	NULL
kinase	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

In	NULL
agreement	NULL
with	NULL
the	NULL
up-regulation	NULL
of	NULL
COX-2	NULL
transcript	NULL
levels	NULL
(	NULL
Fig	NULL
.	NULL

1	NULL
)	NULL
,	NULL
calcium	NULL
ionophore	NULL
and	NULL
PDBu	NULL
cooperated	NULL
with	NULL
truncated	NULL
Cot	NULL
kinase	NULL
in	NULL
the	NULL
activation	NULL
of	NULL
COX-2	NULL
promoter	NULL
(	NULL
Fig	NULL
.	NULL

3	NULL
)	NULL
.	NULL

Cot	NULL
kinase	NULL
also	NULL
cooperated	NULL
with	NULL
«	NULL
-CD3	NULL
,	NULL
«	NULL
-CD28	NULL
,	NULL
or	NULL
calcium	NULL
ionophore	NULL
but	NULL
not	NULL
with	NULL
PDBu	NULL
in	NULL
the	NULL
induction	NULL
of	NULL
COX-2	NULL
promoter	NULL
transcription	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Identification	NULL
of	NULL
the	NULL
Cis-acting	NULL
Elements	NULL
Involved	NULL
in	NULL
COX-2	NULL
Promoter	NULL
Up-regulation	NULL
by	NULL
Cot	NULL
Kinase-It	NULL
is	NULL
known	NULL
that	NULL
Cot	NULL
kinase	NULL
up-regulates	NULL
gene	NULL
transcription	NULL
through	NULL
activation	NULL
of	NULL
NF-kB	NULL
(	NULL
16-18	NULL
)	NULL
.	NULL

On	NULL
the	NULL
other	NULL
hand	NULL
,	NULL
the	NULL
presence	NULL
of	NULL
a	NULL
functional	NULL
NF-KB	NULL
site	NULL
in	NULL
the	NULL
COX-2	NULL
promoter	NULL
located	NULL
at	NULL
-223/-214	NULL
has	NULL
been	NULL
reported	NULL
.	NULL

Therefore	NULL
,	NULL
we	NULL
next	NULL
decided	NULL
to	NULL
analyze	NULL
the	NULL
role	NULL
of	NULL
this	NULL
site	NULL
in	NULL
the	NULL
activation	NULL
of	NULL
COX-2	NULL
promoter	NULL
by	NULL
Cot	NULL
kinase	NULL
in	NULL
T	NULL
cells	NULL
.	NULL

For	NULL
this	NULL
,	NULL
we	NULL
compared	NULL
the	NULL
behavior	NULL
of	NULL
constructs	NULL
P2-431	NULL
(	NULL
containing	NULL
this	NULL
NF-KB	NULL
site	NULL
)	NULL
,	NULL
P2-274	NULL
(	NULL
a	NULL
deletion	NULL
lacking	NULL
this	NULL
site	NULL
)	NULL
,	NULL
and	NULL
a	NULL
construct	NULL
in	NULL
which	NULL
the	NULL
NF-	NULL
«	NULL
B	NULL
site	NULL
was	NULL
mutated	NULL
(	NULL
P2-431	NULL
«	NULL
kB-mut	NULL
)	NULL
in	NULL
response	NULL
to	NULL
Cot	NULL
kinase	NULL
overexpression	NULL
.	NULL

The	NULL
results	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

44	NULL
indicated	NULL
that	NULL
these	NULL
constructs	NULL
were	NULL
equally	NULL
stimulated	NULL
in	NULL
response	NULL
to	NULL
Cot	NULL
kinase	NULL
or	NULL
PDBu	NULL
plus	NULL
calcium	NULL
ionophore	NULL
treatment	NULL
,	NULL
discarding	NULL
a	NULL
role	NULL
of	NULL
this	NULL
NF-	NULL
«	NULL
B	NULL
site	NULL
in	NULL
the	NULL
activation	NULL
of	NULL
COX-2	NULL
promoter	NULL
by	NULL
Cot	NULL
kinase	NULL
in	NULL
T	NULL
cells	NULL
(	NULL
Fig	NULL
.	NULL

4A	NULL
)	NULL
.	NULL

As	NULL
a	NULL
control	NULL
,	NULL
Cot	NULL
kinase	NULL
effectively	NULL
induced	NULL
transcription	NULL
of	NULL
luciferase	NULL
reporter	NULL
gene	NULL
p3x-	NULL
«	NULL
B	NULL
,	NULL
containing	NULL
a	NULL
trimer	NULL
of	NULL
a	NULL
NF-kB	NULL
response	NULL
element	NULL
(	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

The	NULL
role	NULL
of	NULL
NF-kB	NULL
in	NULL
COX-2	NULL
promoter	NULL
activation	NULL
was	NULL
investigated	NULL
further	NULL
by	NULL
co-transfecting	NULL
p65	NULL
NF-kB	NULL
together	NULL
with	NULL
P2-481	NULL
or	NULL
P2-274	NULL
.	NULL

As	NULL
a	NULL
control	NULL
of	NULL
NF-	NULL
«	NULL
B-driven	NULL
transcription	NULL
stimulation	NULL
,	NULL
p65	NULL
NF-	NULL
«	NULL
B	NULL
was	NULL
cotransfected	NULL
with	NULL
the	NULL
reporter	NULL
p3x-	NULL
«	NULL
B	NULL
luciferase	NULL
.	NULL

Transfection	NULL
of	NULL
p65	NULL
did	NULL
not	NULL
increase	NULL
the	NULL
transcriptional	NULL
activity	NULL
of	NULL
P2-431	NULL
COX-2	NULL
but	NULL
increased	NULL
by	NULL
about	NULL
4.5-fold	NULL
the	NULL
driven	NULL
transcription	NULL
activity	NULL
of	NULL
p3x-	NULL
«	NULL
B	NULL
(	NULL
Fig	NULL
.	NULL

4B	NULL
)	NULL
.	NULL

Taken	NULL
together	NULL
the	NULL
above	NULL
results	NULL
discard	NULL
a	NULL
role	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
in	NULL
the	NULL
activation	NULL
of	NULL
COX-2	NULL
promoter	NULL
by	NULL
Cot	NULL
kinase	NULL
in	NULL
T	NULL
cells	NULL
.	NULL

The	NULL
role	NULL
of	NULL
the	NULL
distal	NULL
(	NULL
dNFAT	NULL
)	NULL
and	NULL
proximal	NULL
(	NULL
pNFAT	NULL
)	NULL
NFAT	NULL
sites	NULL
of	NULL
the	NULL
COX-2	NULL
promoter	NULL
in	NULL
the	NULL
activation	NULL
by	NULL
Cot	NULL
kinase	NULL
was	NULL
investigated	NULL
by	NULL
performing	NULL
cotransfection	NULL
experiments	NULL
with	NULL
P2-274	NULL
COX-2	NULL
promoter	NULL
mutated	NULL
in	NULL
any	NULL
of	NULL
these	NULL
sites	NULL
or	NULL
in	NULL
both	NULL
,	NULL
together	NULL
with	NULL
pEF-BOS	NULL
trunc-Cot	NULL
.	NULL

Mutation	NULL
of	NULL
either	NULL
pNFAT	NULL
or	NULL
dNFAT	NULL
sites	NULL
in	NULL
the	NULL
P2-274	NULL
COX-2	NULL
promoter	NULL
partially	NULL
decreased	NULL
the	NULL
activation	NULL
by	NULL
Cot	NULL
kinase	NULL
.	NULL

Interestingly	NULL
,	NULL
mutation	NULL
of	NULL
both	NULL
NFAT	NULL
sites	NULL
abolished	NULL
the	NULL
induction	NULL
of	NULL
P2-274	NULL
COX-2	NULL
promoter	NULL
transcription	NULL
triggered	NULL
by	NULL
Cot	NULL
kinase	NULL
(	NULL
Fig	NULL
.	NULL

5A	NULL
)	NULL
.	NULL

These	NULL
data	NULL
suggest	NULL
that	NULL
induction	NULL
of	NULL
COX-2	NULL
promoter	NULL
occurs	NULL
through	NULL
activation	NULL
of	NULL
NFAT	NULL
transcription	NULL
fac-tor	NULL
.	NULL

Moreover	NULL
,	NULL
overexpression	NULL
of	NULL
NFAT	NULL
wt	NULL
synergized	NULL
with	NULL
610Z	NULL
'01	NULL
Aepy	NULL
uo	NULL
1san8	NULL
4g	NULL
/S10-aqf	NULL
/	NULL
wroj	NULL
;	NULL
Transcriptional	NULL
Activation	NULL
of	NULL
Cyclooxygenase-2	NULL
by	NULL
Cot	NULL
Kinase	NULL
truncated	NULL
Cot	NULL
kinase	NULL
in	NULL
the	NULL
induction	NULL
of	NULL
COX-2	NULL
promoter	NULL
(	NULL
around	NULL
40-fold	NULL
)	NULL
.	NULL

Stimulation	NULL
by	NULL
calcium	NULL
ionophore	NULL
plus	NULL
PDBu	NULL
of	NULL
these	NULL
transfected	NULL
cells	NULL
increased	NULL
COX-2	NULL
promoter	NULL
activity	NULL
further	NULL
(	NULL
120-fold	NULL
)	NULL
(	NULL
Fig	NULL
.	NULL

5B	NULL
)	NULL
.	NULL

Conversely	NULL
,	NULL
overexpression	NULL
of	NULL
a	NULL
dominant	NULL
negative	NULL
version	NULL
of	NULL
NFAT	NULL
(	NULL
dnNFAT	NULL
)	NULL
blocked	NULL
the	NULL
P2-274	NULL
COX-2	NULL
promoter-driven	NULL
transcription	NULL
induced	NULL
by	NULL
truncated	NULL
Cot	NULL
kinase	NULL
as	NULL
well	NULL
as	NULL
that	NULL
triggered	NULL
by	NULL
calcium	NULL
ionophore	NULL
plus	NULL
PDBu	NULL
stimulation	NULL
(	NULL
Fig	NULL
.	NULL

5B	NULL
)	NULL
.	NULL

It	NULL
has	NULL
been	NULL
shown	NULL
previously	NULL
that	NULL
Cot	NULL
kinase	NULL
activates	NULL
AP-1	NULL
p2-274	NULL
200	NULL
10000	NULL
150	NULL
~	NULL
4	NULL
8000	NULL
.	NULL

€	NULL
a	NULL
2	NULL
6000	NULL
100	NULL
3	NULL
4000	NULL
IC	NULL
50	NULL
2000	NULL
p	NULL
A-	NULL
]	NULL
o	NULL
trunc-Cot	NULL
_	NULL
-	NULL
-	NULL
+	NULL
+	NULL
R	NULL
L	NULL
4	NULL
4	NULL
Tamé7	NULL
=	NULL
+	NULL
=	NULL
+	NULL
-	NULL
+	NULL
.	NULL

+	NULL
Fig	NULL
.	NULL

6	NULL
.	NULL

Role	NULL
of	NULL
c-Jun	NULL
in	NULL
the	NULL
up-regulation	NULL
of	NULL
COX-2	NULL
promoter	NULL
by	NULL
Cot	NULL
kinase	NULL
.	NULL

Cells	NULL
were	NULL
transfected	NULL
with	NULL
0.75	NULL
ug/ml	NULL
P2-274	NULL
constructs	NULL
together	NULL
with	NULL
0.35	NULL
ug/ml	NULL
pEF-BOS	NULL
or	NULL
pEF-BOS	NULL
trunc-Cot	NULL
in	NULL
the	NULL
presence	NULL
or	NULL
absence	NULL
of	NULL
0.35	NULL
ug/ml	NULL
of	NULL
the	NULL
expression	NULL
vector	NULL
TAM67	NULL
,	NULL
and	NULL
they	NULL
were	NULL
stimulated	NULL
or	NULL
not	NULL
with	NULL
50	NULL
ng/ml	NULL
PDBu	NULL
(	NULL
PDB	NULL
)	NULL
and	NULL
1	NULL
um	NULL
calcium	NULL
ionophore	NULL
(	NULL
Zor	NULL
)	NULL
.	NULL

The	NULL
graphs	NULL
show	NULL
the	NULL
mean	NULL
of	NULL
fold	NULL
induction	NULL
of	NULL
two	NULL
different	NULL
experiments	NULL
given	NULL
as	NULL
the	NULL
value	NULL
of	NULL
1	NULL
to	NULL
the	NULL
luciferase	NULL
activity	NULL
obtained	NULL
with	NULL
cells	NULL
transfected	NULL
with	NULL
P2-274	NULL
and	NULL
pEF-BOS	NULL
.	NULL

A	NULL
Fig	NULL
.	NULL

7	NULL
.	NULL

Regulation	NULL
of	NULL
the	NULL
Cot	NULL
kinase-induced	NULL
COX-2	NULL
promoter	NULL
activation	NULL
by	NULL
CsA	NULL
and	NULL
calcineurin	NULL
.	NULL

Pane	NULL
!	NULL

A	NULL
,	NULL
Jurkat	NULL
cells	NULL
were	NULL
transfected	NULL
with	NULL
0.75	NULL
ug/ml	NULL
P2-274	NULL
together	NULL
with	NULL
0.35	NULL
ug/ml	NULL
pEF-BOS	NULL
trunc-Cot	NULL
or	NULL
pEF-BOS	NULL
.	NULL

100	NULL
ng/ml	NULL
CsA	NULL
was	NULL
added	NULL
1	NULL
h	NULL
before	NULL
the	NULL
50	NULL
ng/ml	NULL
PDBu	NULL
(	NULL
PDB	NULL
)	NULL
and	NULL
1	NULL
uM	NULL
calcium	NULL
ionophore	NULL
(	NULL
Zon	NULL
)	NULL
overnight	NULL
stimulation	NULL
.	NULL

B	NULL
The	NULL
graph	NULL
shows	NULL
the	NULL
RLU	NULL
values	NULL
of	NULL
two	NULL
27007	NULL
(	NULL
10	NULL
,	NULL
12	NULL
,	NULL
14	NULL
)	NULL
so	NULL
we	NULL
next	NULL
decided	NULL
to	NULL
study	NULL
the	NULL
role	NULL
of	NULL
this	NULL
transcription	NULL
factor	NULL
in	NULL
the	NULL
up-regulation	NULL
of	NULL
the	NULL
COX-2	NULL
promoter	NULL
by	NULL
Cot	NULL
kinase	NULL
.	NULL

For	NULL
this	NULL
,	NULL
Jurkat	NULL
cells	NULL
were	NULL
cotransfected	NULL
with	NULL
P2-274	NULL
and	NULL
pEF-BOS	NULL
trunc-Cot	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
a	NULL
dominant	NULL
negative	NULL
version	NULL
of	NULL
c-Jun	NULL
,	NULL
named	NULL
TAM67	NULL
.	NULL

Overexpression	NULL
of	NULL
TAM67	NULL
did	NULL
not	NULL
modify	NULL
the	NULL
induction	NULL
of	NULL
COX-2	NULL
promoter	NULL
by	NULL
Cot	NULL
kinase	NULL
(	NULL
Fig	NULL
.	NULL

6	NULL
)	NULL
.	NULL

On	NULL
the	NULL
contrary	NULL
,	NULL
it	NULL
decreased	NULL
COX-2	NULL
promoter-driven	NULL
transcription	NULL
induced	NULL
by	NULL
PDBu	NULL
plus	NULL
calcium	NULL
ionophore	NULL
(	NULL
Ref	NULL
.	NULL

21	NULL
and	NULL
Fig	NULL
.	NULL

6	NULL
)	NULL
as	NULL
well	NULL
as	NULL
the	NULL
activation	NULL
triggered	NULL
by	NULL
truncated	NULL
Cot	NULL
kinase	NULL
together	NULL
with	NULL
PDBu	NULL
plus	NULL
calcium	NULL
ionophore	NULL
stimulation	NULL
(	NULL
Fig	NULL
.	NULL

6	NULL
)	NULL
.	NULL

Involvement	NULL
of	NULL
the	NULL
Calcineurin/	NULL
NFAT	NULL
Pathway	NULL
in	NULL
the	NULL
Activation	NULL
of	NULL
COX-2	NULL
Promoter	NULL
by	NULL
Cot	NULL
Kinase-The	NULL
immunosuppres-sive	NULL
drug	NULL
CsA	NULL
inhibits	NULL
calcineurin	NULL
activity	NULL
and	NULL
consequently	NULL
blocks	NULL
the	NULL
nuclear	NULL
translocation	NULL
of	NULL
NFAT	NULL
(	NULL
43	NULL
)	NULL
.	NULL

Addition	NULL
of	NULL
CsA	NULL
inhibited	NULL
the	NULL
stimulation	NULL
of	NULL
the	NULL
COX-2	NULL
promoter	NULL
induced	NULL
by	NULL
PDBu	NULL
plus	NULL
calcium	NULL
ionophore	NULL
as	NULL
expected	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
the	NULL
up-regulation	NULL
of	NULL
COX-2	NULL
promoter	NULL
induced	NULL
by	NULL
Cot	NULL
kinase	NULL
was	NULL
CsA-independent	NULL
(	NULL
Fig	NULL
.	NULL

7A	NULL
)	NULL
.	NULL

Cotransfection	NULL
of	NULL
ACAM-AI	NULL
(	NULL
an	NULL
activated	NULL
form	NULL
of	NULL
calcineurin	NULL
)	NULL
increased	NULL
COX-2	NULL
promoter	NULL
activity	NULL
about	NULL
3-fold	NULL
(	NULL
Fig	NULL
.	NULL

7B	NULL
)	NULL
.	NULL

Mutation	NULL
of	NULL
any	NULL
of	NULL
the	NULL
proximal	NULL
or	NULL
distal	NULL
NFAT	NULL
sites	NULL
in	NULL
P2-274	NULL
COX-2	NULL
promoter	NULL
abolished	NULL
this	NULL
up-regulation	NULL
.	NULL

Strikingly	NULL
,	NULL
ACAM-AI	NULL
synergized	NULL
with	NULL
Cot	NULL
kinase	NULL
in	NULL
COX-2	NULL
promoter	NULL
activation	NULL
(	NULL
270-fold	NULL
)	NULL
(	NULL
Fig	NULL
.	NULL

7B	NULL
)	NULL
.	NULL

Mutation	NULL
of	NULL
any	NULL
of	NULL
the	NULL
proximal	NULL
or	NULL
distal	NULL
NFAT	NULL
sites	NULL
in	NULL
P2-274	NULL
COX-2	NULL
promoter	NULL
significantly	NULL
decreased	NULL
(	NULL
by	NULL
60-80	NULL
%	NULL
)	NULL
up-regulation	NULL
of	NULL
COX-2	NULL
transcription	NULL
triggered	NULL
by	NULL
overexpression	NULL
of	NULL
ACAM-AI	NULL
together	NULL
with	NULL
truncated	NULL
Cot	NULL
kinase	NULL
.	NULL

Full	NULL
abrogation	NULL
occurs	NULL
when	NULL
both	NULL
sites	NULL
were	NULL
mutated	NULL
.	NULL

Cot	NULL
Kinase	NULL
Up-regulates	NULL
the	NULL
Transactivation	NULL
Function	NULL
of	NULL
q	NULL
98	NULL
No	NULL
addition	NULL
PDB+lon	NULL
vector	NULL
590	NULL
140	NULL
wtrunc-Cot|	NULL
+700	NULL
120	NULL
;	NULL
F600	NULL
C	NULL
100	NULL
,	NULL
500	NULL
``	NULL
&	NULL
<	NULL
7	NULL
3	NULL
so	NULL
400	NULL
3	NULL
60	NULL
F300	NULL
40	NULL
;	NULL
+200	NULL
20	NULL
F100	NULL
0+	NULL
0	NULL
CsA	NULL
-	NULL
CsA	NULL
experiments	NULL
performed	NULL
in	NULL
duplicate	NULL
+	NULL
soo	NULL
S.D	NULL
.	NULL

Panel	NULL
B	NULL
,	NULL
Jurkat	NULL
cells	NULL
were	NULL
trans-	NULL
soo	NULL
fected	NULL
with	NULL
0.75	NULL
ug/ml	NULL
of	NULL
the	NULL
different	NULL
P2-	NULL
400	NULL
274	NULL
constructs	NULL
(	NULL
with	NULL
no	NULL
mutation	NULL
,	NULL
300	NULL
pNFAT-mut	NULL
,	NULL
dNFAT-mut	NULL
,	NULL
or	NULL
d	NULL
&	NULL
pNFAT-	NULL
200	NULL
mut	NULL
)	NULL
together	NULL
with	NULL
0.35	NULL
ug/ml	NULL
pEF-BOS	NULL
-100	NULL
{	NULL
or	NULL
pEF-BOS	NULL
trunc-Cot	NULL
in	NULL
the	NULL
presence	NULL
or	NULL
absence	NULL
of	NULL
0.35	NULL
pg/ml	NULL
ACAM-AL	NULL
.	NULL

86	NULL
h	NULL
after	NULL
transfection	NULL
luciferase	NULL
activity	NULL
was	NULL
measured	NULL
.	NULL

The	NULL
graph	NULL
shows	NULL
the	NULL
RLU	NULL
values	NULL
of	NULL
two	NULL
different	NULL
experiments	NULL
per-	NULL
6-formed	NULL
in	NULL
duplicate	NULL
+	NULL
S.D	NULL
.	NULL

RLUs	NULL
(	NULL
10	NULL
%	NULL
p2-274	NULL
p2-274dmut	NULL
p2-274pmut	NULL
p2-274d	NULL
&	NULL
pmut	NULL
trunc-Cot	NULL
ACAM-Al	NULL
+	NULL
+	NULL
+	NULL
-	NULL
--	NULL
+o	NULL
+	NULL
+0	NULL
+	NULL
-	NULL
~	NULL
-	NULL
+	NULL
+	NULL
+	NULL
+	NULL
-	NULL
-	NULL
+	NULL
+o	NULL
+	NULL
+	NULL
+0	NULL
+	NULL
+0	NULL
+	NULL
-	NULL
+o	NULL
+	NULL
+0	NULL
+	NULL
+	NULL
+	NULL
-o	NULL
+	NULL
-	NULL
+	NULL
+	NULL
-o	NULL
+	NULL
+	NULL
+	NULL
610Z	NULL
'01	NULL
Aepy	NULL
uo	NULL
1san8	NULL
4g	NULL
/S10-aqf	NULL
/	NULL
wroj	NULL
;	NULL
27008	NULL
A	NULL
GAL4-DBD	NULL
GAL4-RANFAT1	NULL
(	NULL
1-415	NULL
)	NULL
|l=lControl	NULL
lDControl	NULL
@	NULL
PDB+lon|	NULL
@	NULL
PDB+lon	NULL
500	NULL
450	NULL
400	NULL
350	NULL
I	NULL
300	NULL
250	NULL
200	NULL
150	NULL
100	NULL
50	NULL
0	NULL
t	NULL
t	NULL
r	NULL
GAL4-LUC	NULL
+	NULL
+	NULL
+	NULL
+	NULL
+	NULL
+	NULL
Vector	NULL
+	NULL
-	NULL
-	NULL
+	NULL
-	NULL
.	NULL

Cot	NULL
~	NULL
+	NULL
=	NULL
-	NULL
+	NULL
trunc-Cot	NULL
h	NULL
~	NULL
+	NULL
-	NULL
-	NULL
+	NULL
RLUs	NULL
(	NULL
103	NULL
)	NULL
B	NULL
GAL4-hNFAT1	NULL
(	NULL
1-415	NULL
)	NULL
45	NULL
-	NULL
No	NULL
addition	NULL
a	NULL
-	NULL
PDB	NULL
+	NULL
fon	NULL
409	NULL
mCsA	NULL
T	NULL
o	NULL
5	NULL
|	NULL
300J	NULL
504	NULL
2	NULL
:	NULL
2004	NULL
I	NULL
RLU	NULL
(	NULL
103	NULL
)	NULL
_A	NULL
a	NULL
P	NULL
GAL4-LUC	NULL
+	NULL
+	NULL
+	NULL
+	NULL
+	NULL
+	NULL
Vector	NULL
+	NULL
-	NULL
~	NULL
+	NULL
=	NULL
t	NULL
Cot	NULL
-	NULL
+	NULL
-	NULL
-	NULL
+	NULL
=	NULL
trunc-Cot	NULL
-	NULL
-	NULL
+	NULL
-	NULL
~	NULL
+	NULL
Fic	NULL
.	NULL

8	NULL
.	NULL

Cot	NULL
kinase	NULL
induces	NULL
transactivation	NULL
mediated	NULL
by	NULL
NFAT	NULL
.	NULL

Panel	NULL
A	NULL
,	NULL
cells	NULL
were	NULL
cotransfected	NULL
with	NULL
0.3	NULL
ug/ml	NULL
GALA-NFAT	NULL
or	NULL
GAL4-DBD	NULL
together	NULL
with	NULL
0.5	NULL
ug/ml	NULL
GAL4-luciferase	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
0.35	NULL
ug/ml	NULL
pEF-BOS	NULL
,	NULL
pEF-BOS	NULL
Cot	NULL
,	NULL
or	NULL
pEF-BOS	NULL
trunc-Cot	NULL
.	NULL

Cells	NULL
were	NULL
stimulated	NULL
or	NULL
not	NULL
with	NULL
50	NULL
ng/ml	NULL
PDBu	NULL
(	NULL
PDB	NULL
)	NULL
and	NULL
1	NULL
uM	NULL
calcium	NULL
ionophore	NULL
(	NULL
Jon	NULL
)	NULL
,	NULL
and	NULL
luciferase	NULL
activity	NULL
was	NULL
measured	NULL
.	NULL

The	NULL
graph	NULL
shows	NULL
the	NULL
RLU	NULL
values	NULL
of	NULL
two	NULL
different	NULL
experiments	NULL
performed	NULL
in	NULL
duplicate	NULL
+	NULL
S.D	NULL
.	NULL

Panel	NULL
B	NULL
,	NULL
cells	NULL
were	NULL
cotransfected	NULL
with	NULL
0.3	NULL
ug/ml	NULL
GAL4-NFAT	NULL
or	NULL
0.5	NULL
ug/ml	NULL
GAL4A-luciferase	NULL
in	NULL
the	NULL
presence	NULL
or	NULL
absence	NULL
of	NULL
0.35	NULL
ug/ml	NULL
pEF-BOS	NULL
,	NULL
pEF-BOS	NULL
Cot	NULL
,	NULL
or	NULL
pEF-BOS	NULL
trunc-Cot	NULL
.	NULL

1	NULL
h	NULL
before	NULL
stimulation	NULL
100	NULL
ng/ml	NULL
CsA	NULL
was	NULL
added	NULL
.	NULL

Cells	NULL
were	NULL
stimulated	NULL
or	NULL
not	NULL
with	NULL
50	NULL
ng/ml	NULL
PDBu	NULL
(	NULL
PDB	NULL
)	NULL
and	NULL
1	NULL
uM	NULL
calcium	NULL
ionophore	NULL
(	NULL
Zon	NULL
)	NULL
,	NULL
and	NULL
luciferase	NULL
activity	NULL
was	NULL
measured	NULL
.	NULL

The	NULL
graph	NULL
shows	NULL
the	NULL
RLU	NULL
values	NULL
of	NULL
two	NULL
different	NULL
experiments	NULL
performed	NULL
in	NULL
duplicate	NULL
+	NULL
S.D	NULL
.	NULL

NFAT-The	NULL
above	NULL
results	NULL
suggest	NULL
that	NULL
Cot	NULL
kinase	NULL
was	NULL
acting	NULL
on	NULL
the	NULL
NFAT	NULL
pathway	NULL
in	NULL
parallel	NULL
to	NULL
calcineurin	NULL
.	NULL

It	NULL
has	NULL
been	NULL
described	NULL
that	NULL
phorbol	NULL
ester	NULL
and	NULL
calcium	NULL
ionophore	NULL
stimulation	NULL
of	NULL
NFAT	NULL
does	NULL
not	NULL
only	NULL
involve	NULL
its	NULL
nuclear	NULL
translocation	NULL
,	NULL
but	NULL
also	NULL
the	NULL
optimal	NULL
function	NULL
of	NULL
the	NULL
transactivation	NULL
domain	NULL
located	NULL
at	NULL
the	NULL
N	NULL
terminus	NULL
domain	NULL
of	NULL
NFAT	NULL
(	NULL
85	NULL
,	NULL
36	NULL
,	NULL
44	NULL
)	NULL
.	NULL

To	NULL
study	NULL
the	NULL
implication	NULL
of	NULL
Cot	NULL
kinase	NULL
in	NULL
the	NULL
transactivation	NULL
of	NULL
NFAT	NULL
,	NULL
cotransfection	NULL
experiments	NULL
of	NULL
Cot	NULL
kinase	NULL
together	NULL
with	NULL
GAL4-NFATp	NULL
were	NULL
performed	NULL
.	NULL

The	NULL
GAL4-NFATp	NULL
fusion	NULL
protein	NULL
is	NULL
constitutively	NULL
expressed	NULL
in	NULL
the	NULL
nucleus	NULL
because	NULL
of	NULL
the	NULL
strong	NULL
nuclear	NULL
localization	NULL
signal	NULL
at	NULL
the	NULL
N	NULL
terminus	NULL
of	NULL
GAL4	NULL
(	NULL
45	NULL
)	NULL
and	NULL
contains	NULL
the	NULL
N-terminal	NULL
transactivation	NULL
domain	NULL
of	NULL
NFATp	NULL
.	NULL

Overexpression	NULL
of	NULL
both	NULL
truncated	NULL
or	NULL
wild	NULL
type	NULL
Cot	NULL
strongly	NULL
potentiated	NULL
the	NULL
function	NULL
of	NULL
the	NULL
NFAT	NULL
transactivation	NULL
domain	NULL
(	NULL
Fig	NULL
.	NULL

8A	NULL
)	NULL
.	NULL

As	NULL
a	NULL
control	NULL
,	NULL
Cot	NULL
kinase	NULL
did	NULL
not	NULL
induce	NULL
activity	NULL
when	NULL
cotransfected	NULL
with	NULL
GAL4-DBD	NULL
.	NULL

Similar	NULL
to	NULL
what	NULL
we	NULL
observed	NULL
with	NULL
the	NULL
inducibility	NULL
of	NULL
the	NULL
COX-2	NULL
promoter	NULL
,	NULL
truncated	NULL
Cot	NULL
kinase	NULL
activated	NULL
more	NULL
effectively	NULL
than	NULL
wild	NULL
type	NULL
Cot	NULL
kinase	NULL
transactivation	NULL
mediated	NULL
by	NULL
NFAT	NULL
.	NULL

Even	NULL
more	NULL
,	NULL
CsA	NULL
inhibited	NULL
NFAT	NULL
transactivation	NULL
induced	NULL
by	NULL
phorbol	NULL
esters	NULL
plus	NULL
calcium	NULL
ionophore	NULL
,	NULL
but	NULL
not	NULL
by	NULL
Cot	NULL
kinase	NULL
activity	NULL
,	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
any	NULL
additional	NULL
stimulus	NULL
(	NULL
Fig	NULL
.	NULL

8B	NULL
)	NULL
.	NULL

Transcriptional	NULL
Activation	NULL
of	NULL
Cyclooxygenase-2	NULL
by	NULL
Cot	NULL
Kinase	NULL
T	NULL
cell	NULL
activation	NULL
f	NULL
p	NULL
(	NULL
Cot	NULL
kinase	NULL
)	NULL
\	NULL
cytoplasm	NULL
nucleus	NULL
___A	NULL
LS	NULL
105	NULL
-76	NULL
COX-2	NULL
gene	NULL
expression	NULL
Fic	NULL
.	NULL

9	NULL
.	NULL

Model	NULL
of	NULL
activation	NULL
of	NULL
COX-2	NULL
gene	NULL
expression	NULL
by	NULL
Cot	NULL
kinase	NULL
in	NULL
T	NULL
cells	NULL
.	NULL

Induction	NULL
Cox-2	NULL
in	NULL
T	NULL
cells	NULL
upon	NULL
T	NULL
cell	NULL
receptor	NULL
triggering	NULL
occurs	NULL
mainly	NULL
through	NULL
activation	NULL
of	NULL
NFAT	NULL
.	NULL

Cot	NULL
kinase	NULL
participates	NULL
in	NULL
this	NULL
induction	NULL
by	NULL
activating	NULL
NFAT-dependent	NULL
transactivation	NULL
signaling	NULL
pathway	NULL
in	NULL
a	NULL
CsA-insensitive	NULL
manner	NULL
thus	NULL
acting	NULL
downstream	NULL
or	NULL
in	NULL
a	NULL
parallel	NULL
pathway	NULL
to	NULL
that	NULL
mediated	NULL
by	NULL
calcineurin	NULL
.	NULL

DISCUSSION	NULL
COX-2	NULL
has	NULL
been	NULL
implicated	NULL
in	NULL
inflammation	NULL
processes	NULL
and	NULL
is	NULL
the	NULL
target	NULL
of	NULL
many	NULL
nonsteroidal	NULL
anti-inflammatory	NULL
drugs	NULL
(	NULL
19	NULL
)	NULL
.	NULL

More	NULL
recently	NULL
,	NULL
COX-2	NULL
has	NULL
been	NULL
also	NULL
associated	NULL
with	NULL
oncogenic	NULL
transformation	NULL
and	NULL
angiogenesis	NULL
(	NULL
46-57	NULL
)	NULL
.	NULL

We	NULL
have	NULL
previously	NULL
described	NULL
that	NULL
COX-2	NULL
is	NULL
induced	NULL
upon	NULL
antigenic	NULL
triggering	NULL
in	NULL
resting	NULL
T	NULL
cells	NULL
,	NULL
where	NULL
it	NULL
plays	NULL
a	NULL
role	NULL
in	NULL
controlling	NULL
the	NULL
process	NULL
of	NULL
T	NULL
cell	NULL
activation	NULL
(	NULL
20	NULL
,	NULL
21	NULL
)	NULL
.	NULL

In	NULL
this	NULL
report	NULL
we	NULL
have	NULL
found	NULL
that	NULL
Cot	NULL
kinase	NULL
is	NULL
involved	NULL
in	NULL
the	NULL
regulation	NULL
of	NULL
COX-2	NULL
transcription	NULL
in	NULL
T	NULL
cells	NULL
.	NULL

The	NULL
fact	NULL
that	NULL
a	NULL
kinase-deficient	NULL
mutant	NULL
of	NULL
Cot	NULL
kinase	NULL
blocked	NULL
the	NULL
activation	NULL
of	NULL
COX-2	NULL
promoter	NULL
induced	NULL
by	NULL
«	NULL
-CD3	NULL
and	NULL
«	NULL
-CD28	NULL
,	NULL
as	NULL
well	NULL
as	NULL
by	NULL
phorbol	NULL
esters	NULL
plus	NULL
calcium	NULL
ionophore	NULL
,	NULL
indicates	NULL
that	NULL
Cot	NULL
kinase	NULL
or	NULL
a	NULL
Cot-like	NULL
kinase	NULL
plays	NULL
a	NULL
pivotal	NULL
role	NULL
in	NULL
the	NULL
up-regulation	NULL
of	NULL
COX-2	NULL
gene	NULL
expression	NULL
upon	NULL
T	NULL
cell	NULL
activation	NULL
.	NULL

Cot	NULL
kinase	NULL
regulates	NULL
the	NULL
activity	NULL
of	NULL
several	NULL
transcription	NULL
factors	NULL
induced	NULL
in	NULL
T	NULL
cell	NULL
activation	NULL
such	NULL
as	NULL
NFAT	NULL
,	NULL
AP-1	NULL
,	NULL
or	NULL
NF-kB	NULL
(	NULL
10-18	NULL
)	NULL
.	NULL

Previous	NULL
results	NULL
indicate	NULL
that	NULL
Cot	NULL
kinase	NULL
increases	NULL
interleukin-2	NULL
gene	NULL
expression	NULL
(	NULL
14-16	NULL
)	NULL
mainly	NULL
by	NULL
up-regulating	NULL
the	NULL
transcription	NULL
driven	NULL
by	NULL
NF-kB	NULL
and	NULL
the	NULL
composite	NULL
element	NULL
NFAT-AP-1	NULL
of	NULL
interleukin-2	NULL
promoter	NULL
(	NULL
16	NULL
)	NULL
;	NULL
Cot	NULL
kinase	NULL
also	NULL
up-regulates	NULL
the	NULL
AP-1	NULL
response	NULL
element	NULL
of	NULL
the	NULL
collagenase	NULL
promoter	NULL
(	NULL
12	NULL
,	NULL
14	NULL
,	NULL
16	NULL
)	NULL
.	NULL

It	NULL
has	NULL
been	NULL
shown	NULL
that	NULL
COX-2	NULL
promoter	NULL
contains	NULL
binding	NULL
sites	NULL
for	NULL
these	NULL
transcription	NULL
factors	NULL
,	NULL
acting	NULL
as	NULL
positive	NULL
regulatory	NULL
elements	NULL
of	NULL
COX-2	NULL
transcription	NULL
in	NULL
several	NULL
cell	NULL
types	NULL
(	NULL
22-34	NULL
)	NULL
.	NULL

However	NULL
,	NULL
we	NULL
have	NULL
shown	NULL
here	NULL
that	NULL
activation	NULL
of	NULL
COX-2	NULL
promoter	NULL
in	NULL
T	NULL
cells	NULL
occurs	NULL
in	NULL
a	NULL
NF-kB-independent	NULL
manner	NULL
,	NULL
in	NULL
agreement	NULL
with	NULL
previous	NULL
results	NULL
discarding	NULL
a	NULL
role	NULL
of	NULL
this	NULL
transcription	NULL
factor	NULL
in	NULL
this	NULL
cell	NULL
type	NULL
.	NULL

On	NULL
the	NULL
other	NULL
hand	NULL
,	NULL
a	NULL
dominant	NULL
negative	NULL
mutant	NULL
of	NULL
c-Jun	NULL
inhibits	NULL
PDBu	NULL
plus	NULL
calcium	NULL
ionophore	NULL
activation	NULL
of	NULL
COX-2	NULL
promoter	NULL
,	NULL
pointing	NULL
to	NULL
an	NULL
important	NULL
role	NULL
of	NULL
those	NULL
signaling	NULL
pathways	NULL
leading	NULL
to	NULL
AP-1	NULL
activation	NULL
(	NULL
21	NULL
)	NULL
.	NULL

However	NULL
,	NULL
this	NULL
mutant	NULL
did	NULL
not	NULL
affect	NULL
Cot	NULL
kinase-mediated	NULL
induction	NULL
of	NULL
Cox-2	NULL
promoter	NULL
,	NULL
suggesting	NULL
that	NULL
Cot	NULL
could	NULL
act	NULL
through	NULL
a	NULL
c-Jun-independent	NULL
pathway	NULL
to	NULL
activate	NULL
this	NULL
promoter	NULL
.	NULL

Data	NULL
obtained	NULL
with	NULL
the	NULL
COX-2	NULL
promoter	NULL
deletion	NULL
constructs	NULL
or	NULL
with	NULL
those	NULL
with	NULL
distal	NULL
and	NULL
proximal	NULL
NFAT	NULL
sites	NULL
mutated	NULL
,	NULL
as	NULL
well	NULL
as	NULL
the	NULL
overexpression	NULL
of	NULL
a	NULL
dominant	NULL
negative	NULL
version	NULL
of	NULL
NFAT	NULL
,	NULL
indicate	NULL
that	NULL
NFAT	NULL
is	NULL
required	NULL
for	NULL
Cot-mediated	NULL
or	NULL
PDBu	NULL
plus	NULL
calcium	NULL
ionophore	NULL
up-regulation	NULL
of	NULL
COX-2	NULL
promoter	NULL
.	NULL

The	NULL
striking	NULL
synergism	NULL
between	NULL
wtNFAT	NULL
or	NULL
ACAM-AI	NULL
and	NULL
Cot	NULL
kinase	NULL
and	NULL
the	NULL
fact	NULL
that	NULL
CsA	NULL
did	NULL
not	NULL
inhibit	NULL
Cot	NULL
kinase-mediated	NULL
Cox-2	NULL
promoter	NULL
induction	NULL
supports	NULL
the	NULL
hypothesis	NULL
that	NULL
Cot	NULL
kinase-induced	NULL
NFAT-dependent	NULL
transacti-	NULL
610Z	NULL
'01	NULL
Aepy	NULL
uo	NULL
1san8	NULL
4g	NULL
/S10-aqf	NULL
/	NULL
wroj	NULL
;	NULL
Transcriptional	NULL
Activation	NULL
of	NULL
Cyclooxygenase-2	NULL
by	NULL
Cot	NULL
Kinase	NULL
vation	NULL
is	NULL
either	NULL
downstream	NULL
of	NULL
calcineurin	NULL
,	NULL
or	NULL
it	NULL
represents	NULL
a	NULL
parallel	NULL
pathway	NULL
(	NULL
Fig	NULL
.	NULL

9	NULL
)	NULL
.	NULL

Here	NULL
,	NULL
we	NULL
show	NULL
that	NULL
Cot	NULL
kinase	NULL
mediated	NULL
up-regulation	NULL
of	NULL
genes	NULL
transactivated	NULL
by	NULL
NFAT	NULL
occurs	NULL
through	NULL
the	NULL
increase	NULL
in	NULL
the	NULL
transactivation	NULL
function	NULL
of	NULL
NFAT	NULL
.	NULL

The	NULL
Cot	NULL
kinase	NULL
induced-transactivation	NULL
by	NULL
NFAT	NULL
described	NULL
here	NULL
can	NULL
explain	NULL
why	NULL
Cot	NULL
kinase	NULL
up-regulates	NULL
COX-2	NULL
promoter	NULL
activity	NULL
through	NULL
their	NULL
NFAT	NULL
sites	NULL
in	NULL
addition	NULL
to	NULL
NFAT	NULL
binding	NULL
to	NULL
these	NULL
sites	NULL
.	NULL

Moreover	NULL
,	NULL
the	NULL
up-regulation	NULL
of	NULL
transactivation	NULL
by	NULL
NFAT	NULL
and	NULL
the	NULL
induction	NULL
of	NULL
COX-2	NULL
promoter-driven	NULL
transcription	NULL
by	NULL
Cot	NULL
kinase	NULL
are	NULL
both	NULL
CsA-independent	NULL
and	NULL
could	NULL
also	NULL
explain	NULL
the	NULL
reported	NULL
CsA-insensitive	NULL
activation	NULL
of	NULL
interleukin-2	NULL
and	NULL
tumor	NULL
necrosis	NULL
factor-a	NULL
gene	NULL
by	NULL
Cot	NULL
kinase	NULL
in	NULL
T	NULL
cells	NULL
(	NULL
15	NULL
,	NULL
14	NULL
)	NULL
.	NULL

NFAT	NULL
transcription	NULL
factors	NULL
are	NULL
regulated	NULL
at	NULL
two	NULL
different	NULL
levels	NULL
,	NULL
primarily	NULL
at	NULL
the	NULL
level	NULL
of	NULL
subcellular	NULL
localization	NULL
and	NULL
secondarily	NULL
at	NULL
the	NULL
level	NULL
of	NULL
the	NULL
intrinsic	NULL
DNA	NULL
binding	NULL
activity	NULL
.	NULL

Tsatsanis	NULL
et	NULL
al	NULL
.	NULL

(	NULL
15	NULL
)	NULL
have	NULL
reported	NULL
the	NULL
regulation	NULL
of	NULL
NFAT	NULL
by	NULL
Cot	NULL
kinase	NULL
at	NULL
the	NULL
level	NULL
of	NULL
subcellular	NULL
localization	NULL
.	NULL

Thus	NULL
,	NULL
they	NULL
have	NULL
shown	NULL
that	NULL
overexpression	NULL
of	NULL
Cot	NULL
kinase	NULL
induces	NULL
the	NULL
nuclear	NULL
accumulation	NULL
of	NULL
HA-NFATc	NULL
in	NULL
the	NULL
3T3	NULL
fibroblasts	NULL
.	NULL

An	NULL
integration	NULL
of	NULL
signal	NULL
promoted	NULL
by	NULL
phorbol	NULL
esters	NULL
and	NULL
calcium	NULL
ionophore	NULL
is	NULL
required	NULL
to	NULL
increase	NULL
the	NULL
transactivation	NULL
by	NULL
NFAT	NULL
(	NULL
35	NULL
,	NULL
36	NULL
,	NULL
44	NULL
)	NULL
.	NULL

However	NULL
,	NULL
PDBu	NULL
plus	NULL
calcium	NULL
ionophore	NULL
activation	NULL
of	NULL
the	NULL
NFAT	NULL
transactivation	NULL
domain	NULL
is	NULL
CsA-sensitive	NULL
(	NULL
85	NULL
,	NULL
36	NULL
,	NULL
and	NULL
this	NULL
report	NULL
)	NULL
in	NULL
contrast	NULL
to	NULL
what	NULL
we	NULL
observed	NULL
with	NULL
Cot	NULL
kinase	NULL
.	NULL

In	NULL
this	NULL
context	NULL
,	NULL
it	NULL
remains	NULL
to	NULL
be	NULL
established	NULL
whether	NULL
the	NULL
reported	NULL
accumulation	NULL
of	NULL
NFATce	NULL
by	NULL
Cot	NULL
kinase	NULL
in	NULL
the	NULL
nucleus	NULL
(	NULL
15	NULL
)	NULL
is	NULL
a	NULL
consequence	NULL
of	NULL
the	NULL
increase	NULL
of	NULL
transactivation	NULL
function	NULL
of	NULL
NFAT	NULL
triggered	NULL
by	NULL
Cot	NULL
kinase	NULL
which	NULL
thereby	NULL
retained	NULL
it	NULL
in	NULL
the	NULL
nucleus	NULL
.	NULL

Another	NULL
possibility	NULL
is	NULL
that	NULL
Cot	NULL
kinase	NULL
regulates	NULL
both	NULL
the	NULL
NFAT	NULL
in/out	NULL
shuttling	NULL
of	NULL
the	NULL
nucleus	NULL
and	NULL
transactivation	NULL
by	NULL
NFAT	NULL
by	NULL
different	NULL
ways	NULL
,	NULL
but	NULL
with	NULL
a	NULL
common	NULL
finality	NULL
,	NULL
to	NULL
induce	NULL
promoter	NULL
transcription	NULL
through	NULL
NFAT	NULL
response	NULL
elements	NULL
.	NULL

In	NULL
conclusion	NULL
,	NULL
the	NULL
data	NULL
shown	NULL
here	NULL
indicate	NULL
that	NULL
Cot	NULL
kinase	NULL
controls	NULL
COX-2	NULL
promoter	NULL
activity	NULL
mainly	NULL
,	NULL
if	NULL
not	NULL
exclusively	NULL
,	NULL
through	NULL
the	NULL
NFAT	NULL
response	NULL
elements	NULL
.	NULL

We	NULL
also	NULL
provide	NULL
evidence	NULL
of	NULL
a	NULL
new	NULL
mechanism	NULL
of	NULL
NFAT	NULL
transcription	NULL
factor	NULL
activity	NULL
up-regulation	NULL
by	NULL
Cot	NULL
kinase	NULL
which	NULL
helps	NULL
to	NULL
explain	NULL
the	NULL
important	NULL
role	NULL
of	NULL
this	NULL
kinase	NULL
in	NULL
the	NULL
regulation	NULL
of	NULL
gene	NULL
expression	NULL
after	NULL
T	NULL
cell	NULL
activation	NULL
.	NULL

Further	NULL
analysis	NULL
remains	NULL
to	NULL
be	NULL
done	NULL
to	NULL
define	NULL
the	NULL
interactions	NULL
between	NULL
Cot	NULL
kinase	NULL
and	NULL
the	NULL
N-termi-	NULL
nal	NULL
transactivation	NULL
domain	NULL
of	NULL
NFAT	NULL
.	NULL

Acknowledgments-We	NULL
thank	NULL
Joaquin	NULL
Pérez	NULL
and	NULL
Maria	NULL
Chorro	NULL
for	NULL
the	NULL
technical	NULL
assistance	NULL
,	NULL
Dr.	NULL
Arnero	NULL
(	NULL
Sandoz	NULL
,	NULL
Espafia	NULL
)	NULL
for	NULL
cyclosporin	NULL
A	NULL
and	NULL
V.	NULL
Calvo	NULL
and	NULL
A.	NULL
Bardon	NULL
for	NULL
critical	NULL
reading	NULL
of	NULL
the	NULL
manuscript	NULL
.	NULL

We	NULL
thank	NULL
Drs	NULL
.	NULL

Alcami	NULL
,	NULL
Crabtree	NULL
,	NULL
and	NULL
Burgering	NULL
for	NULL
the	NULL
different	NULL
constructs	NULL
.	NULL

REFERENCES	NULL
1	NULL
.	NULL

Salmerén	NULL
,	NULL
A.	NULL
,	NULL
Ahmad	NULL
,	NULL
T.	NULL
B.	NULL
,	NULL
Carlille	NULL
,	NULL
G.	NULL
W.	NULL
,	NULL
Pappin	NULL
,	NULL
D.	NULL
,	NULL
Narsimham	NULL
,	NULL
R.	NULL
P.	NULL
,	NULL
and	NULL
Ley	NULL
,	NULL
S.	NULL
C.	NULL
(	NULL
1996	NULL
)	NULL
EMBO	NULL
J	NULL
.	NULL

15	NULL
,	NULL
817-826	NULL
2	NULL
.	NULL

Fanger	NULL
,	NULL
G.	NULL
R.	NULL
,	NULL
Gerwins	NULL
,	NULL
P.	NULL
,	NULL
Widmann	NULL
,	NULL
C.	NULL
,	NULL
Jarpe	NULL
,	NULL
M.	NULL
B.	NULL
,	NULL
and	NULL
Johnson	NULL
,	NULL
G.	NULL
L.	NULL
(	NULL
1997	NULL
)	NULL
Curr	NULL
.	NULL

Opin	NULL
.	NULL

Gen.	NULL
Dev	NULL
.	NULL

7	NULL
,	NULL
67-174	NULL
3	NULL
.	NULL

Hunter	NULL
,	NULL
T.	NULL
(	NULL
1997	NULL
)	NULL
Cell	NULL
88	NULL
,	NULL
333-346	NULL
4	NULL
.	NULL

Patriotis	NULL
,	NULL
C.	NULL
,	NULL
Makris	NULL
,	NULL
A.	NULL
,	NULL
Bear	NULL
,	NULL
S.	NULL
E.	NULL
,	NULL
and	NULL
Tsichlis	NULL
,	NULL
P.	NULL
N.	NULL
(	NULL
1998	NULL
)	NULL
Proc	NULL
.	NULL

Naf	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

U.	NULL
S.	NULL
A	NULL
.	NULL

90	NULL
,	NULL
2251-2255	NULL
.	NULL

Robinson	NULL
,	NULL
M.	NULL
J.	NULL
,	NULL
and	NULL
Cobb	NULL
,	NULL
M.	NULL
H.	NULL
(	NULL
1997	NULL
)	NULL
Curr	NULL
.	NULL

Opin	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

9	NULL
,	NULL
180-186	NULL
.	NULL

Miyoshi	NULL
,	NULL
J.	NULL
,	NULL
Higashi	NULL
,	NULL
T.	NULL
,	NULL
Mukai	NULL
,	NULL
H.	NULL
,	NULL
Ohuchi	NULL
,	NULL
T.	NULL
,	NULL
and	NULL
Kakunaga	NULL
,	NULL
T.	NULL
(	NULL
1991	NULL
)	NULL
Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

11	NULL
,	NULL
4088-4096	NULL
7	NULL
.	NULL

Aoki	NULL
,	NULL
M.	NULL
,	NULL
Akiyama	NULL
,	NULL
T.	NULL
,	NULL
Miyoshi	NULL
,	NULL
J.	NULL
,	NULL
and	NULL
Toyoshima	NULL
,	NULL
K.	NULL
(	NULL
1991	NULL
)	NULL
Oncogene	NULL
6	NULL
,	NULL
1515-1519	NULL
8	NULL
.	NULL

Aoki	NULL
,	NULL
M.	NULL
,	NULL
Hamada	NULL
,	NULL
F.	NULL
,	NULL
Sugimoto	NULL
,	NULL
T.	NULL
,	NULL
Sumida	NULL
,	NULL
S.	NULL
,	NULL
Akiyama	NULL
,	NULL
T.	NULL
,	NULL
and	NULL
Toyoshima	NULL
,	NULL
K.	NULL
(	NULL
1993	NULL
)	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

268	NULL
,	NULL
22728-22731	NULL
9	NULL
.	NULL

Chan	NULL
,	NULL
A.	NULL
M.-L.	NULL
,	NULL
Chedid	NULL
,	NULL
M.	NULL
,	NULL
McGovern	NULL
,	NULL
E.	NULL
S.	NULL
,	NULL
Popescu	NULL
,	NULL
N.	NULL
C.	NULL
,	NULL
Miki	NULL
,	NULL
T.	NULL
,	NULL
and	NULL
Aaronson	NULL
,	NULL
S.	NULL
A	NULL
.	NULL

(	NULL
1993	NULL
)	NULL
Oncogene	NULL
8	NULL
,	NULL
1329-1333	NULL
10	NULL
.	NULL

Chiarello	NULL
,	NULL
M.	NULL
,	NULL
Marinsen	NULL
,	NULL
M.	NULL
J.	NULL
,	NULL
and	NULL
Gutkind	NULL
,	NULL
J.	NULL
S.	NULL
(	NULL
2000	NULL
)	NULL
Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

20	NULL
,	NULL
1747-1758	NULL
11	NULL
.	NULL

Patriotis	NULL
,	NULL
C.	NULL
,	NULL
Makris	NULL
,	NULL
A.	NULL
M.	NULL
,	NULL
Chernoff	NULL
,	NULL
J.	NULL
,	NULL
and	NULL
Tsichlis	NULL
,	NULL
P.	NULL
N.	NULL
(	NULL
1994	NULL
)	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sei	NULL
.	NULL

U.	NULL
S.	NULL
A	NULL
.	NULL

91	NULL
,	NULL
9755-9759	NULL
12	NULL
.	NULL

18	NULL
.	NULL

14	NULL
.	NULL

15	NULL
.	NULL

16	NULL
.	NULL

17	NULL
.	NULL

18	NULL
.	NULL

19	NULL
.	NULL

20	NULL
.	NULL

21	NULL
.	NULL

22	NULL
.	NULL

28	NULL
.	NULL

24	NULL
.	NULL

25	NULL
.	NULL

26	NULL
.	NULL

27	NULL
.	NULL

28	NULL
.	NULL

29	NULL
.	NULL

30	NULL
.	NULL

31	NULL
.	NULL

32	NULL
.	NULL

33	NULL
.	NULL

34	NULL
.	NULL

35	NULL
.	NULL

36	NULL
.	NULL

37	NULL
.	NULL

38	NULL
.	NULL

39	NULL
.	NULL

40	NULL
.	NULL

41	NULL
.	NULL

42	NULL
.	NULL

43	NULL
.	NULL

44	NULL
.	NULL

45	NULL
.	NULL

46	NULL
.	NULL

47	NULL
.	NULL

48	NULL
.	NULL

49	NULL
.	NULL

50	NULL
.	NULL

51	NULL
.	NULL

52	NULL
.	NULL

53	NULL
.	NULL

54	NULL
.	NULL

55	NULL
.	NULL

56	NULL
.	NULL

57	NULL
.	NULL

27009	NULL
Hagemann	NULL
,	NULL
D.	NULL
,	NULL
Troppmair	NULL
,	NULL
J.	NULL
,	NULL
and	NULL
Rapp	NULL
,	NULL
U.	NULL
R.	NULL
(	NULL
1999	NULL
)	NULL
Oncogene	NULL
18	NULL
,	NULL
1391-1400	NULL
Ballester	NULL
,	NULL
A.	NULL
,	NULL
Calvo	NULL
,	NULL
V.	NULL
,	NULL
Tobefia	NULL
,	NULL
R.	NULL
,	NULL
Lisbona	NULL
,	NULL
C.	NULL
,	NULL
and	NULL
Alemany	NULL
,	NULL
S.	NULL
(	NULL
1997	NULL
)	NULL
J.	NULL
Immunol	NULL
.	NULL

159	NULL
,	NULL
1613-1618	NULL
Ballester	NULL
,	NULL
A.	NULL
,	NULL
Velasco	NULL
,	NULL
A.	NULL
,	NULL
Tobefia	NULL
,	NULL
R.	NULL
,	NULL
and	NULL
Alemany	NULL
,	NULL
S.	NULL
(	NULL
1998	NULL
)	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

278	NULL
,	NULL
14099-14106	NULL
Tsatsanis	NULL
,	NULL
C.	NULL
,	NULL
Patriotis	NULL
,	NULL
C.	NULL
,	NULL
Bear	NULL
,	NULL
S.	NULL
E.	NULL
,	NULL
and	NULL
Tsichlis	NULL
,	NULL
P.	NULL
N.	NULL
(	NULL
1998	NULL
)	NULL
Proc	NULL
.	NULL

Naf	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

U.	NULL
S.	NULL
A	NULL
.	NULL

95	NULL
,	NULL
3827-3832	NULL
Tsatsanis	NULL
,	NULL
C.	NULL
,	NULL
Patriotis	NULL
,	NULL
C.	NULL
,	NULL
and	NULL
Tsichlis	NULL
,	NULL
P.	NULL
N.	NULL
(	NULL
1998	NULL
)	NULL
Oncogene	NULL
19	NULL
,	NULL
2609-2618	NULL
Belich	NULL
,	NULL
M.	NULL
P.	NULL
,	NULL
Salmeron	NULL
,	NULL
A.	NULL
,	NULL
Johnston	NULL
,	NULL
L.	NULL
H.	NULL
,	NULL
and	NULL
Ley	NULL
,	NULL
S.	NULL
C.	NULL
(	NULL
1999	NULL
)	NULL
Nature	NULL
897	NULL
,	NULL
363-368	NULL
Lin	NULL
,	NULL
X.	NULL
,	NULL
Cunningham	NULL
,	NULL
E.	NULL
T.	NULL
,	NULL
Jr.	NULL
,	NULL
Mu	NULL
,	NULL
Y.	NULL
,	NULL
Geleziunas	NULL
,	NULL
R.	NULL
,	NULL
and	NULL
Greene	NULL
,	NULL
W.	NULL
C.	NULL
(	NULL
1999	NULL
)	NULL
Immunity	NULL
10	NULL
,	NULL
271-280	NULL
Smith	NULL
,	NULL
W.	NULL
L.	NULL
,	NULL
DeWitt	NULL
,	NULL
D.	NULL
L.	NULL
,	NULL
and	NULL
Garavito	NULL
,	NULL
M.	NULL
(	NULL
2000	NULL
)	NULL
Annu	NULL
.	NULL

Rev	NULL
.	NULL

Biochem	NULL
.	NULL

69	NULL
,	NULL
145-182	NULL
Thiguez	NULL
,	NULL
M.	NULL
A.	NULL
,	NULL
Punzéon	NULL
,	NULL
C.	NULL
,	NULL
and	NULL
Fresno	NULL
,	NULL
M.	NULL
(	NULL
1999	NULL
)	NULL
J.	NULL
Immunol	NULL
.	NULL

168	NULL
,	NULL
111-119	NULL
M.	NULL
A.	NULL
,	NULL
Martinez-Martinez	NULL
,	NULL
S.	NULL
,	NULL
Punzon	NULL
,	NULL
C.	NULL
,	NULL
Redondo	NULL
,	NULL
J.	NULL
M.	NULL
,	NULL
and	NULL
Fresno	NULL
,	NULL
M.	NULL
(	NULL
2000	NULL
)	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

275	NULL
,	NULL
28627-23635	NULL
Subbaramaiah	NULL
,	NULL
K.	NULL
,	NULL
Hart	NULL
,	NULL
J.	NULL
C.	NULL
,	NULL
Norton	NULL
,	NULL
L.	NULL
,	NULL
and	NULL
Dannenberg	NULL
,	NULL
A.	NULL
J	NULL
.	NULL

(	NULL
2000	NULL
)	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

275	NULL
,	NULL
14838-14845	NULL
Adderley	NULL
,	NULL
S.	NULL
R.	NULL
,	NULL
and	NULL
Fitzgerald	NULL
,	NULL
D.	NULL
J	NULL
.	NULL

(	NULL
1999	NULL
)	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

274	NULL
,	NULL
5038-5046	NULL
von	NULL
Knethen	NULL
,	NULL
A.	NULL
,	NULL
Callsen	NULL
,	NULL
D.	NULL
,	NULL
and	NULL
Brine	NULL
,	NULL
B	NULL
.	NULL

(	NULL
1999	NULL
)	NULL
Mol	NULL
.	NULL

Biol	NULL
.	NULL

Cell	NULL
10	NULL
,	NULL
361-872	NULL
Yamamoto	NULL
,	NULL
K.	NULL
,	NULL
Arakawa	NULL
,	NULL
T.	NULL
,	NULL
Ueda	NULL
,	NULL
T.	NULL
,	NULL
and	NULL
Tamamoto	NULL
,	NULL
S.	NULL
(	NULL
1995	NULL
)	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

270	NULL
,	NULL
31315-32768	NULL
Schmedjte	NULL
,	NULL
J.	NULL
F.	NULL
,	NULL
Jr.	NULL
,	NULL
Ji	NULL
,	NULL
Y.	NULL
S.	NULL
,	NULL
Liu	NULL
,	NULL
W.	NULL
L.	NULL
,	NULL
DuBois	NULL
,	NULL
R.	NULL
N.	NULL
,	NULL
and	NULL
Runge	NULL
,	NULL
M.	NULL
S.	NULL
(	NULL
1997	NULL
)	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

272	NULL
,	NULL
601-608	NULL
Crofford	NULL
,	NULL
L.	NULL
J.	NULL
,	NULL
Tan	NULL
,	NULL
B.	NULL
,	NULL
McCarthy	NULL
,	NULL
C.	NULL
J.	NULL
,	NULL
and	NULL
Hla	NULL
,	NULL
T.	NULL
(	NULL
1997	NULL
)	NULL
Arthritis	NULL
Rheum	NULL
.	NULL

40	NULL
,	NULL
226-236	NULL
Newton	NULL
,	NULL
R.	NULL
,	NULL
Kuitert	NULL
,	NULL
L.	NULL
M.	NULL
,	NULL
Bergmann	NULL
,	NULL
M.	NULL
,	NULL
Adcock	NULL
,	NULL
I.	NULL
M.	NULL
,	NULL
and	NULL
Barnes	NULL
,	NULL
P.	NULL
J	NULL
.	NULL

(	NULL
1997	NULL
)	NULL
Biochem	NULL
.	NULL

Biophys	NULL
.	NULL

Res	NULL
.	NULL

Commun	NULL
.	NULL

287	NULL
,	NULL
28-82	NULL
Chen	NULL
,	NULL
C.	NULL
C.	NULL
,	NULL
Sun	NULL
,	NULL
Y.	NULL
T.	NULL
,	NULL
Chen	NULL
,	NULL
J.	NULL
J.	NULL
,	NULL
and	NULL
Chiu	NULL
,	NULL
K.	NULL
T.	NULL
(	NULL
2000	NULL
)	NULL
J.	NULL
Immunol	NULL
.	NULL

165	NULL
,	NULL
2719-2728	NULL
Inoue	NULL
,	NULL
H.	NULL
,	NULL
and	NULL
Tanabe	NULL
,	NULL
T.	NULL
(	NULL
1998	NULL
)	NULL
Biochem	NULL
.	NULL

Biophys	NULL
.	NULL

Res	NULL
.	NULL

Commun	NULL
.	NULL

244	NULL
,	NULL
148-148	NULL
Nakao	NULL
,	NULL
S.	NULL
,	NULL
Ogata	NULL
,	NULL
Y.	NULL
,	NULL
Shimizu-Sasaki	NULL
,	NULL
E.	NULL
,	NULL
Yamazaki	NULL
,	NULL
M.	NULL
,	NULL
Furuyama	NULL
,	NULL
S.	NULL
,	NULL
and	NULL
Sugiya	NULL
,	NULL
H.	NULL
(	NULL
2000	NULL
)	NULL
Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biochem	NULL
.	NULL

209	NULL
,	NULL
113-118	NULL
Yan	NULL
,	NULL
Z.	NULL
,	NULL
Subbaramaiah	NULL
,	NULL
K.	NULL
,	NULL
Camilli	NULL
,	NULL
T.	NULL
,	NULL
Zhang	NULL
,	NULL
F.	NULL
,	NULL
Tanabe	NULL
,	NULL
T.	NULL
,	NULL
McCaffrey	NULL
,	NULL
T.	NULL
A.	NULL
,	NULL
Dannenberg	NULL
,	NULL
A.	NULL
J.	NULL
,	NULL
and	NULL
Weksler	NULL
,	NULL
B	NULL
.	NULL

B	NULL
.	NULL

(	NULL
2000	NULL
)	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

275	NULL
,	NULL
4949-4955	NULL
Zhang	NULL
,	NULL
F.	NULL
,	NULL
Subbaramaiah	NULL
,	NULL
K.	NULL
,	NULL
Altorki	NULL
,	NULL
N.	NULL
,	NULL
and	NULL
Dannenberg	NULL
,	NULL
A.	NULL
J	NULL
.	NULL

(	NULL
1998	NULL
)	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

278	NULL
,	NULL
2424-2428	NULL
Subbaramaiah	NULL
,	NULL
K.	NULL
,	NULL
Chung	NULL
,	NULL
W.	NULL
J.	NULL
,	NULL
Michaluart	NULL
,	NULL
P.	NULL
,	NULL
Telang	NULL
,	NULL
N.	NULL
,	NULL
Tanabe	NULL
,	NULL
T.	NULL
,	NULL
Inoue	NULL
,	NULL
H.	NULL
,	NULL
Jang	NULL
,	NULL
M.	NULL
,	NULL
Pezzuto	NULL
,	NULL
J.	NULL
M.	NULL
,	NULL
and	NULL
Dannenberg	NULL
,	NULL
A.	NULL
J	NULL
.	NULL

(	NULL
1998	NULL
)	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

278	NULL
,	NULL
21875-21883	NULL
Rao	NULL
,	NULL
A.	NULL
,	NULL
Luo	NULL
,	NULL
C.	NULL
,	NULL
and	NULL
Hogan	NULL
,	NULL
P.	NULL
G.	NULL
(	NULL
1997	NULL
)	NULL
Arnu	NULL
.	NULL

Rev	NULL
.	NULL

Immunol	NULL
.	NULL

15	NULL
,	NULL
707-747	NULL
Garcia-Rodriguez	NULL
,	NULL
C.	NULL
,	NULL
and	NULL
Rao	NULL
,	NULL
A	NULL
.	NULL

(	NULL
2000	NULL
)	NULL
Eur	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

80	NULL
,	NULL
2482-2436	NULL
Arenzana-Seisdedos	NULL
,	NULL
F.	NULL
,	NULL
Fernandez	NULL
,	NULL
B.	NULL
,	NULL
Dominguez	NULL
,	NULL
L.	NULL
,	NULL
Jacque	NULL
,	NULL
J.	NULL
M.	NULL
,	NULL
Thomas	NULL
,	NULL
D.	NULL
,	NULL
Diaz-Meco	NULL
,	NULL
M.	NULL
T.	NULL
,	NULL
Moscat	NULL
,	NULL
J.	NULL
,	NULL
and	NULL
Virelizier	NULL
,	NULL
J.	NULL
L.	NULL
(	NULL
1998	NULL
)	NULL
J.	NULL
Virol	NULL
.	NULL

67	NULL
,	NULL
6596-6604	NULL
Northrop	NULL
,	NULL
J.	NULL
P.	NULL
,	NULL
Ho	NULL
,	NULL
S.	NULL
N.	NULL
,	NULL
Chen	NULL
,	NULL
L.	NULL
,	NULL
Thomas	NULL
,	NULL
C.	NULL
J.	NULL
,	NULL
Timmerman	NULL
,	NULL
L.	NULL
A.	NULL
,	NULL
Nolan	NULL
,	NULL
G.	NULL
P.	NULL
,	NULL
Admon	NULL
,	NULL
A.	NULL
,	NULL
and	NULL
Crabtree	NULL
,	NULL
G.	NULL
R.	NULL
(	NULL
1994	NULL
)	NULL
Nature	NULL
869	NULL
,	NULL
497-502	NULL
O'Keefe	NULL
,	NULL
S.	NULL
J.	NULL
,	NULL
Tamura	NULL
,	NULL
J.	NULL
,	NULL
Kincaid	NULL
,	NULL
R.	NULL
L.	NULL
,	NULL
Tocci	NULL
,	NULL
M.	NULL
J.	NULL
,	NULL
and	NULL
O'Neill	NULL
,	NULL
E.	NULL
A	NULL
.	NULL

(	NULL
1992	NULL
)	NULL
Nature	NULL
857	NULL
,	NULL
692-694	NULL
Luo	NULL
,	NULL
C.	NULL
,	NULL
Burgeon	NULL
,	NULL
E.	NULL
,	NULL
Carew	NULL
,	NULL
J	NULL
.	NULL

A.	NULL
,	NULL
McAffrey	NULL
,	NULL
P.	NULL
G.	NULL
,	NULL
Badalian	NULL
,	NULL
T.	NULL
M.	NULL
,	NULL
Lane	NULL
,	NULL
W.	NULL
S.	NULL
,	NULL
Hogan	NULL
,	NULL
P.	NULL
S.	NULL
,	NULL
and	NULL
Rao	NULL
,	NULL
A	NULL
.	NULL

(	NULL
1996	NULL
)	NULL
Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

16	NULL
,	NULL
3955-3966	NULL
Baniahmad	NULL
,	NULL
A.	NULL
,	NULL
Kohne	NULL
,	NULL
A.	NULL
C.	NULL
,	NULL
and	NULL
Renkawitz	NULL
,	NULL
R.	NULL
(	NULL
1992	NULL
)	NULL
EMBO	NULL
J	NULL
.	NULL

11	NULL
,	NULL
1015-1023	NULL
Minden	NULL
,	NULL
A.	NULL
,	NULL
Lin	NULL
,	NULL
A.	NULL
,	NULL
Claret	NULL
,	NULL
F.-X	NULL
.	NULL

,	NULL
Abo	NULL
,	NULL
A.	NULL
,	NULL
and	NULL
Karin	NULL
,	NULL
M.	NULL
(	NULL
1995	NULL
)	NULL
Cell	NULL
81	NULL
,	NULL
1147-1157	NULL
Flanagan	NULL
,	NULL
W.	NULL
M.	NULL
,	NULL
Corthesy	NULL
,	NULL
B.	NULL
,	NULL
Bram	NULL
,	NULL
R.	NULL
J.	NULL
,	NULL
and	NULL
Crabtree	NULL
,	NULL
G.	NULL
R.	NULL
(	NULL
1991	NULL
)	NULL
Nature	NULL
352	NULL
,	NULL
803-807	NULL
Avots	NULL
,	NULL
A.	NULL
,	NULL
Buttmann	NULL
,	NULL
M.	NULL
,	NULL
Chuypilo	NULL
,	NULL
S.	NULL
,	NULL
Escher	NULL
,	NULL
C.	NULL
,	NULL
Smola	NULL
,	NULL
U.	NULL
,	NULL
Bannister	NULL
,	NULL
A.	NULL
J.	NULL
,	NULL
Rapp	NULL
,	NULL
U.	NULL
R.	NULL
,	NULL
Kouzarides	NULL
,	NULL
T.	NULL
,	NULL
and	NULL
Serfling	NULL
.	NULL

E.	NULL
(	NULL
1999	NULL
)	NULL
Immunity	NULL
10	NULL
,	NULL
515-524	NULL
Siver	NULL
,	NULL
P.	NULL
A.	NULL
,	NULL
Keegan	NULL
,	NULL
L.	NULL
P.	NULL
,	NULL
and	NULL
Ptashine	NULL
,	NULL
M.	NULL
(	NULL
1984	NULL
)	NULL
Proc	NULL
.	NULL

Na	NULL
#	NULL
l	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

U.	NULL
S.	NULL
A	NULL
.	NULL

81	NULL
,	NULL
5951-5955	NULL
Kim	NULL
,	NULL
Y.	NULL
,	NULL
and	NULL
Fischer	NULL
,	NULL
S.	NULL
M.	NULL
(	NULL
1998	NULL
)	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

278	NULL
,	NULL
27686-27694	NULL
Hida	NULL
,	NULL
T.	NULL
,	NULL
Yatabe	NULL
,	NULL
Y.	NULL
,	NULL
Achiwa	NULL
,	NULL
H.	NULL
,	NULL
Muramatsu	NULL
,	NULL
H.	NULL
,	NULL
Kozak	NULL
,	NULL
K.	NULL
,	NULL
Nakamura	NULL
,	NULL
S.	NULL
,	NULL
Ogawa	NULL
,	NULL
M.	NULL
,	NULL
and	NULL
Mitsudomi	NULL
,	NULL
T.	NULL
(	NULL
1998	NULL
)	NULL
Cancer	NULL
Res	NULL
.	NULL

58	NULL
,	NULL
8761-3764	NULL
DuBois	NULL
,	NULL
R.	NULL
N.	NULL
,	NULL
Radhika	NULL
,	NULL
A.	NULL
,	NULL
Reddy	NULL
,	NULL
B.	NULL
S.	NULL
,	NULL
and	NULL
Entingh	NULL
,	NULL
A.	NULL
J	NULL
.	NULL

(	NULL
1996	NULL
)	NULL
Gastroen-terology	NULL
110	NULL
,	NULL
1259-1262	NULL
Sano	NULL
,	NULL
H.	NULL
,	NULL
Kawahito	NULL
,	NULL
Y.	NULL
,	NULL
Wilder	NULL
,	NULL
R.	NULL
L.	NULL
,	NULL
Hashiramoto	NULL
,	NULL
A.	NULL
,	NULL
Mukai	NULL
,	NULL
S.	NULL
,	NULL
Asai	NULL
,	NULL
K.	NULL
,	NULL
Kimura	NULL
,	NULL
S.	NULL
,	NULL
Kato	NULL
,	NULL
H.	NULL
,	NULL
Kondo	NULL
,	NULL
M.	NULL
,	NULL
and	NULL
Hla	NULL
,	NULL
T.	NULL
(	NULL
1995	NULL
)	NULL
Cancer	NULL
Res	NULL
.	NULL

55	NULL
,	NULL
3785-3789	NULL
Brueggemeier	NULL
,	NULL
R.	NULL
W.	NULL
,	NULL
Quinn	NULL
,	NULL
A.	NULL
L.	NULL
,	NULL
Parret	NULL
,	NULL
A.	NULL
L.	NULL
,	NULL
Joarder	NULL
,	NULL
F.	NULL
S.	NULL
,	NULL
Harris	NULL
,	NULL
R.	NULL
E.	NULL
,	NULL
and	NULL
Roberston	NULL
,	NULL
F.	NULL
M.	NULL
(	NULL
1999	NULL
)	NULL
Cancer	NULL
Left	NULL
.	NULL

140	NULL
,	NULL
27-35	NULL
Williams	NULL
,	NULL
C.	NULL
S.	NULL
,	NULL
Mann	NULL
,	NULL
M.	NULL
,	NULL
and	NULL
DuBois	NULL
,	NULL
R.	NULL
N.	NULL
(	NULL
1999	NULL
)	NULL
Oncogene	NULL
20	NULL
,	NULL
7908-7916	NULL
Oshima	NULL
,	NULL
M.	NULL
,	NULL
Dinchuk	NULL
,	NULL
J.	NULL
E.	NULL
,	NULL
Kargman	NULL
,	NULL
S.	NULL
L.	NULL
,	NULL
Oshima	NULL
,	NULL
H.	NULL
,	NULL
Hancock	NULL
,	NULL
B.	NULL
,	NULL
Kwong	NULL
,	NULL
E.	NULL
,	NULL
Traskos	NULL
,	NULL
J.	NULL
M.	NULL
,	NULL
Evans	NULL
,	NULL
J.	NULL
F.	NULL
,	NULL
and	NULL
Taketo	NULL
,	NULL
M.	NULL
M.	NULL
(	NULL
1996	NULL
)	NULL
Cell	NULL
87	NULL
,	NULL
803-809	NULL
Jones	NULL
,	NULL
M.	NULL
K.	NULL
,	NULL
Wang	NULL
,	NULL
H.	NULL
,	NULL
Peskar	NULL
,	NULL
B.	NULL
M.	NULL
,	NULL
Levin	NULL
,	NULL
E.	NULL
,	NULL
Itani	NULL
,	NULL
R.	NULL
M.	NULL
,	NULL
Sarfeb	NULL
,	NULL
I.	NULL
J.	NULL
,	NULL
and	NULL
Tarnawski	NULL
,	NULL
A.	NULL
S.	NULL
(	NULL
1999	NULL
)	NULL
Nat	NULL
.	NULL

Med	NULL
.	NULL

5	NULL
,	NULL
1418-1423	NULL
Zhang	NULL
,	NULL
X.	NULL
,	NULL
Morham	NULL
,	NULL
S.	NULL
G.	NULL
,	NULL
Langenbach	NULL
,	NULL
R.	NULL
,	NULL
and	NULL
Young	NULL
,	NULL
D.	NULL
A	NULL
.	NULL

(	NULL
1999	NULL
)	NULL
J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

190	NULL
,	NULL
451-459	NULL
Sawaoka	NULL
,	NULL
H.	NULL
,	NULL
Kawano	NULL
,	NULL
S.	NULL
,	NULL
Tsuji	NULL
,	NULL
S.	NULL
,	NULL
Tsujii	NULL
,	NULL
M.	NULL
,	NULL
Gunawan	NULL
,	NULL
E.	NULL
S.	NULL
,	NULL
Takei	NULL
,	NULL
Y.	NULL
,	NULL
Nagano	NULL
,	NULL
K.	NULL
,	NULL
and	NULL
Hori	NULL
,	NULL
M.	NULL
(	NULL
1998	NULL
)	NULL
Am	NULL
.	NULL

J.	NULL
Physiol	NULL
.	NULL

274	NULL
,	NULL
1061-1067	NULL
Shen	NULL
,	NULL
G.	NULL
G.	NULL
,	NULL
Shao	NULL
,	NULL
J.	NULL
,	NULL
Sheng	NULL
,	NULL
H.	NULL
,	NULL
Hooton	NULL
,	NULL
E.	NULL
B.	NULL
,	NULL
Isakson	NULL
,	NULL
P.	NULL
C.	NULL
,	NULL
Morrow	NULL
,	NULL
J.	NULL
D.	NULL
,	NULL
Coffey	NULL
,	NULL
R.	NULL
J.	NULL
,	NULL
Jr.	NULL
,	NULL
DuBois	NULL
,	NULL
R.	NULL
N.	NULL
,	NULL
and	NULL
Beauchamp	NULL
,	NULL
R.	NULL
D.	NULL
(	NULL
1997	NULL
)	NULL
Gastroenter-ology	NULL
118	NULL
,	NULL
1883-1891	NULL
Hernandez	NULL
,	NULL
G.	NULL
,	NULL
Volpert	NULL
,	NULL
O.	NULL
V.	NULL
,	NULL
Ifiguez	NULL
,	NULL
M.	NULL
A.	NULL
,	NULL
Lorenzo	NULL
,	NULL
E.	NULL
,	NULL
Martinez-Martinez	NULL
,	NULL
S.	NULL
,	NULL
Grau	NULL
,	NULL
R.	NULL
,	NULL
Fresno	NULL
,	NULL
M.	NULL
,	NULL
and	NULL
Redondo	NULL
,	NULL
J.	NULL
M.	NULL
(	NULL
2001	NULL
)	NULL
J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

198	NULL
,	NULL
607-620	NULL
610Z	NULL
'01	NULL
Aepy	NULL
uo	NULL
1san8	NULL
4g	NULL
/S10-aqf	NULL
/	NULL
wroj	NULL
;	NULL
Cot	NULL
Kinase	NULL
Induces	NULL
Cyclooxygenase-2	NULL
Expression	NULL
in	NULL
T	NULL
Cells	NULL
through	NULL
Activation	NULL
of	NULL
the	NULL
Nuclear	NULL
Factor	NULL
of	NULL
Activated	NULL
T	NULL
Cells	NULL
Rosa	NULL
de	NULL
Gregorio	NULL
,	NULL
Miguel	NULL
A.	NULL
Ifiiguez	NULL
,	NULL
Manuel	NULL
Fresno	NULL
and	NULL
Susana	NULL
Alemany	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

2001	NULL
,	NULL
276:27003-27009.	NULL
doi	NULL
:	NULL
10.1074/jbc.M100885200	NULL
originally	NULL
published	NULL
online	NULL
May	NULL
16	NULL
,	NULL
2001	NULL
Access	NULL
the	NULL
most	NULL
updated	NULL
version	NULL
of	NULL
this	NULL
article	NULL
at	NULL
doi	NULL
:	NULL
10.1074/jbe.M100885200	NULL
Alerts	NULL
:	NULL
«	NULL
When	NULL
this	NULL
article	NULL
is	NULL
cited	NULL
«	NULL
When	NULL
a	NULL
correction	NULL
for	NULL
this	NULL
article	NULL
is	NULL
posted	NULL
Click	NULL
here	NULL
to	NULL
choose	NULL
from	NULL
all	NULL
of	NULL
JBC	NULL
's	NULL
e-mail	NULL
alerts	NULL
This	NULL
article	NULL
cites	NULL
57	NULL
references	NULL
,	NULL
27	NULL
of	NULL
which	NULL
can	NULL
be	NULL
accessed	NULL
free	NULL
at	NULL
http	NULL
:	NULL
//www	NULL
610Z	NULL
'01	NULL
Aepy	NULL
uo	NULL
1san8	NULL
4g	NULL
/S10-aqf	NULL
/	NULL
wroj	NULL
;	NULL

